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Abstract
Despite advances m understanding the basic biology of HIV the aetiological agent of 
AIDS, medica1, public health and health education planning is plagued by uncertain­
ties Mathematical models of the dynamics of HIV transmission and its progression 
to AIDS can clarify what data must be collected in order to  predict future preva­
lence, make predictions about the likely effect of future intervention pobcies and 
provide predictions for several decades ahead The motivation of this research is to 
provide reliable estimates of the incidence of HIV infection and AIDS in the Irish 
population
In Chapters 1 and 2 we discuss the background to the disease in Ireland and the 
role of mathematical modelling m the spread AIDS From this we show where key 
epidemiological data is lacking and how models to date have concentrated on the 
spread of the disease within the homosexual population In Chapter 3 we describe 
the adjustment of the number of AIDS cases to allow for reporting delays Subse­
quently we consider the solution of the integral equation models generated by the 
back-projection method for the adjusted AIDS cases In Chapter 4 we improve upon 
the estimates of the incidence of HIV infection found m Chapter 3 by evaluating the 
integral arising m back-projection, in terms of a gamma function plus a remainder 
in the form of a series in t We also provide error bounds for the remainder This 
new solution allows us to predict new and more reliable estimates of the level of HIV 
infection m Ireland
In Chapter 5 we provide estimates of the minimum number of deaths from AIDS, 
based on the number of AIDS cases known to the Department of Health and the 
distribution of the length of survival times after the onset of AIDS
The results of a HIV transmission survey are presented in Chapter 6 These 
provide detailed information on the habits and behaviour of those at risk of HIV 
infection and allow us to derive preliminary model parameters Finally in Chapter 7 
we develop and implement a nonlinear deterministic differential equation model for 
the spread of HIV and its progression to AIDS m the Irish IVDU and homosexual 
populations We examine the effects of likely intervention policies on the extent and 
spread of the disease and we make recommendations based on our thesis findings
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‘The AIDS epidemic is considered the most serious epidemic of the last 
50 years The word epidemic conjures up a picture of the Black Death 
sweeping across Europe in the 14th century ’ Science, 21st Novem­
ber 1986
‘AIDS Depressing news from Pans ’ Nature, 3rd July 1986 
4Grim Projections for AIDS Epidemic By 1991, some 270,000 people in 
the United States will have AIDS or will have died from the disease, how 
many others will be infected is uncertain, ’ Science, 27th June 1986 
‘AIDS - Ireland moves into European second division ’ Irish Medical 
Times, 1st May 1989
1.1 Introduction
The Director of The AIDS Program, at The Centres for Disease Control (CDC) 
Atlanta, has stated that the first cases of acquired immune deficiency syndrome 
(AIDS) were reported in the U S A  in mid 1981, J W Curran et al (1985) [17] The 
initial occurrence of the syndrome among homosexual men and intravenous drug 
users suggested a transmissible agent as the cause The transmissible hypothesis 
became more widely accepted by early 1983, with the well documented occurrence 
of the syndrome in persons with haemophiha and recipients of blood transfusions 
During the next year a retrovirus variously termed lymphadenopathy-associated 
virus (LAV), human T-lymphotropic virus type III (HTLV-III), or AIDS-associated 
retov iru s (ARV) was isolated and shown to be the cause of AIDS
Despite these considerable advances in understanding the basic biology of the 
human lmmuno-deficiency virus, the aetiological agent of AIDS, we can see from 
the cross section of quotes above that medical, public health and health education 
planning continues to be plagued by uncertainties There remain many questions of 
an epidemiological nature to be answered The questions to be addressed include
How many people are HIV positive now, or will become positive7 
Will the proportion HIV positive be the same m A) the total population,
B) homosexual and C) drug users7
How many HIV positives will develop full blown AIDS and how soon7 
How will this proportion and rate of development be affected by therapy 
with new drugs7
Will reporting delays play an im portant role in data collection7
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How many deaths can we expect from AIDS over the next few years7 
How widespread and prevalent is AIDS at present7
The objective of this thesis is to provide some of the answers to  these questions within 
the Irish situation To achieve this aim we implement and modify internationally 
recognised mathematical models of mathematicians and statisticians in the U K 
and U S A
An obvious way to predict the future course of any epidemic is to extrapolate fig­
ures from the immediate past Such empirical predictions are useful only up to two 
or three years into the future, after which they become too imprecise In the medium 
term, mathematical models of the dynamics of HIV infection and its progression to 
AIDS can facilitate the indirect assessment of the essential epidemiological param­
eters, clarify what data  must be collected in order to predict future prevalence and 
make predictions about the likely effect of alternative intervention policies These 
models can provide predictions for several decades ahead
In order to model any situation be it epidemiological or otherwise, one must first 
have a thorough and m depth knowledge of the phenomena to be modelled One 
must know the crucial aspects of the problem and its essential parameters It is also 
im portant to have a global picture of the problem and to remind oneself regularly 
of the aims and objectives It is all too easy to become engrossed in detail and lose 
sight of the objectives In our next section we provide m detail a global picture of 
HIV and AIDS in Ireland
1 2 The Irish Situation
In this section we aim to provide a global view of AIDS in Ireland We shall compare 
the spread of the disease with other western European and African countries We 
shall see how the pattern of spread m Ireland is very different to that of our closest 
European partner, Britain and our trans-atlantic partner, the United States We 
shall provide a detailed look at the distribution of cases of the HIV virus in Ireland 
and finally we shall discuss the difficulties associated with data collection in Ireland 
and how these affect attem pts at modelling
PA  Sato, J Chm and J M Mann (1989) [46] review the global epidemiology 
and statistics of AIDS and HIV infection They discuss distinctive global epidemiol- 
gical patterns as identified by WHO Three mam patterns have emerged They are 
as follows,
• Pattern  I
-  Extensive spread from the late 1970’s to the early 1980’s
-  Most cases m homosexual/bisexual men and urban intravenous drug 
users
-  Only small percentage of infections heterosexually transm itted
-  Transmission via blood/blood products largely under control
-  Male female ratio about 10 1, thus paediatric AIDS uncommon
-  Transmission through inadequately sterilised needles and syringes not a 
significant mode of spread except among intravenous drug users
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-  Overall HIV prevalence is < 1% but may exceed 50% in groups at high 
risk for infection
• Pattern  II
-  Extensive spread beginning from the late 1970’s to the early 1980’s
-  Most cases among heterosexual men and women
-  Transmission via contaminated blood/blood products remains significant 
in many of these countries f
-  Transmission via inadequately sterilised needles and syringes although 
small, remains of concern
-  National prevalence of HIV infections can exceed 1%, in some urban areas 
up to 25% of those aged 15-49 years are infected
• P attern  III
-  HIV first introduced m the early to  mid 1980’s
-  Only a small number of AIDS cases reported
-  Cases recorded among homosexuals, bisexuals, heterosexuals intravenous 
drug users, transmission through blood/blood products has also occurred
-  Cases mostly in people who have travelled to higher prevalence areas, also 
m people exposed to individuals who have been to such areas
Pattern  I areas are primarily comprised of western industrialised countries In some 
pattern I areas, HIV infection continues to increase in the most socially and econom­
ically vulnerable segments of society Pattern  II areas are comprised of sub-Saharan 
Africa and parts of the Caribbean Here transmission remains predominantly het­
erosexual and the prevalence of HIV infection continues to rise Pattern III regions 
are characterised epidemiologically by the recent onset of the HIV/AIDS pandemic 
In consequence most countries that exhibit this pattern have not as yet shown pre­
dominant modes of transmission, this is however slowly changing
Ireland is classified as a Pattern  I country, yet the first cases of AIDS in Ire­
land were not identified until 1981 We shall also see that paediatric AIDS is not 
uncommon compared with other European countries This is a direct result of the 
male female ratio of HIV cases Table 1 1 summarises this ratio for 1985, when test­
ing first started in Ireland to the year 1989 In this table figures for males include, 
homosexuals, bisexuals, intravenous drug users and haemophiliacs Females include 
intravenous drug users only As information on the sex of those classified as ‘others’ 
(representing 7% of the total HIV positive at the end of 1989) was not available, 
they are not included in the table
Table 1 1 
Male Female ratio of HIV cases
Year Numbers Ratio
1985 251 48 5 2 1
1986 412 75 5 5 1
1987 490 93 5 3 1
1988 545 110 5 0 1
1989 623 125 5 0  1
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We see from Table 1 1 that the male female ratio of HIV infections is well below 
that estimated for pattern I countries This is largely explained by the following 
table, which shows the distribution of known cases of the virus as of December 1989
Table 1 2
Distribution of known HIV cases to the end of December 1989
Risk Group Number Positive % of Total Cases
I V D U
Male 390 42 86
Female 125 13 74
Sex Unknown 5 0 55
Total I V D U 520 57 15
Babies 63 6 92
Homo/Bisexual 121 13 30
Haemophiliac 112 12 30
Blood Donors 15 165
Prisoners 12 1 32
Hetero /  U nspecified 67 7 36
Total Cases 910 100 00
We see from the table above that there were a total of 910 known cases of the 
HIV virus in Ireland at the end of 1989, 57 15% of which were identified in the 
intravenous drug using group, while the homosexual and bisexual group represents 
only 13 30% of all cases This is a direct contradiction of the WHO Pattern I 
countries description In addition, we note tha t paediatric cases comprise almost 
7% of the total identified
If we examine the distribution of AIDS cases at the same time we see that the 
total number of AIDS cases amongst the I V drug users is lower than that of male 
homosexual and bisexuals This is because the first cases of AIDS in Ireland were 
identified m the homosexual/bisexual group in 1981 The first case of AIDS in an 
I V D U was not identified until the second half of 1985 It is interesting to note 
that the first paediatric case also appeared at this time The distribution of reported 
AIDS cases is given in Table 1 3 below
Table 1 3
Distribution of known AIDS cases to the end of December 1989
Risk Group Number of Cases % of Total Cases
I V D U 41 33 06
Homo/Bisexual 48 38 71
Homo/Bi and IVDU 7 5 65
Haemophiliac 16 12 90
Hetero Contact 4 3 23
Paediatric 5 4 03
Other/Unspecified 3 2 42
Total Cases 124 100 00
Given the distribution of both HIV and AIDS cases in Ireland and the fact that
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first cases were identified relatively late it may be prudent to describe a specific 
pattern of spread for the Irish situation In addition within Ireland, homosexuality, 
abortion and the sale of condoms to those under 18 years of age is illegal The Irish 
situation may then be summarised as follows
• Irish P attern
-  Spread early to mid 1980’s
-  Majority of cases amongst male and female Dublin city IV  D U
-  Few cases heterosexually spread though this is increasing
-  Paediatric cases common and increasing
-  Male to female ratio approximately 5 1
-  Transmission via blood/sterilised needles ml excluding early transmission 
amongst haemophiliacs
Now that we have examined the Irish situation in detail we axe m a position to begin 
to consider the modelling of the spread of HIV infection and AIDS in Ireland We 
are also aware of the difficulties that this will involve due to the sensitivity of the 
data  and the lack of key data on the life-styles of the Irish IVDU’s and homosexuals 
In Chapter 2 we begin the modelling process by a careful examination of the 
models currently in the literature We begin with the preliminary compartment 
models of Anderson, Medley, May and Johnson (1986) [5], then we look at the 
further developments by Blythe and Anderson (1988) [9], and finally we look at the 
review of current models by Isham (1988a) [26] In later chapters we shall also refer 
to  models by Dietz (1988) [18]
In Chapter 3 we model the probability distribution of the reporting delay, based 
on the work of Brookmeyer and Damiano (1989) [10] Reporting of diagnosed AIDS 
cases is frequently subject to considerable time lag This reporting delay (or differ­
ence between date of diagnosis and entry in national AIDS records) has important 
implications both for the provision of resources and for modelling the progression 
of the disease In Chapter 3 we also make preliminary estimates of the incidence 
of HIV infection in Ireland using the back projection method and some new forms 
for the growth in AIDS cases, a(i) Knowledge of the distribution of the incuba­
tion period enables us to  work forwards and backwards, i e to predict future AIDS 
cases from those currently HIV positive and, alternatively, to use current adjusted 
figures for AIDS cases to  derive estimates for those previously infected with the HIV 
virus This alternative use of the incubation probability distribution is known as 
‘back-projection’ We show how results derived depend upon, not only the choice of 
incubation period chosen but also the form of a(t)
In Chapter 4 we extend this work and improve on the estimates provided m 
Chapter 3, by the use of the exact incubation distribution as fitted by Anderson 
and Medley (1988) [4] We show how the integral equation model can be changed 
to an Abel integral equation, the solution of which is given in terms of the gamma 
function plus a remainder This new solution allows us to predict new and more 
reliable estimates of the level of HIV infection in the Irish population
In Chapter 5 we provide estimates of the number of deaths each year and preva­
lence of AIDS withm the Irish population Given estimates for the number of AIDS 
cases in Ireland after adjustment for reporting delays, we can provide estimates for 
the likely number of deaths arising from these AIDS cases based on a particular 
choice of the survival function as fitted by Cox (1988) [16] and Reeves and Overton
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(1988) [43] In addition estimates for the prevalence of AIDS in Ireland are provided 
based on the results for deaths
In Chapter 6 we discuss the results from a comprehensive behavioural survey of 
HIV positive patients from the various risk groups The survey was administered 
at the primary Dublin Gem to-Urinary Clinic at St James Hospital The survey 
provides us with an m-depth look at the Me-style and behaviour of HIV positive 
patients From the survey we shall also estimate the parameters required for the 
transmission model in Chapter 7
Finally m Chapter 7 we provide preliminary estimates of the model parameters, 
we also develop our transmission models and describe the results obtained We 
provide predictions on the spread of the HIV virus and AIDS in the Irish IVDU 
population Current models concentrate on the progression of the disease within 
the homosexual population We develop a model centred on the male and female 
drug using populations, which, as we have seen earlier, comprise the main route of 
transmission in Ireland Our results describe the changes in the susceptible, HIV 
infected and AIDS IVDU and homosexual populations
We conclude with our results and we make recommendations to both mathe­
maticians and those concerned with public health on future research needs based on 
the findings of our thesis
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Chapter 2
M odelling The Transm ission  
D ynam ics of H IV  and its  
Progression to A ID S.
2.1 Introduction
Mathematical models of epidemics have a long and varied history First recorded 
accounts of epidemics go back as far as the ancient Greeks of approximately 400 
BC Hippocrates (459 - 377 BC) m his essay on ‘Airs, Waters and Localities’ wrote 
that ones temperament, personal habits and environment were important factors in 
the cause and spread of epidemics In the light of the current AIDS epidemic, many 
would say that his words still ring true
In recent times Kermack and McKendnck (1927) [28] have provided more de­
tailed and elaborate studies of infectious diseases N T J Bailey (1957) [7] provides 
one of the first comprehensive mathematical studies of infectious diseases and of 
host-vector and venereal disease models The monograph by Hethcote and Yorke 
(1984) [24] gives a very good survey of models used for the spread and control of 
gonorrhea In the U S A  it is bebeved that more than 2 million people contract gon­
orrhea annually Finally Murray (1989) [37] discusses modelling venereal diseases in 
general
In this chapter we shall first, critically discuss some general models for the spread 
of the HIV virus and its progression to AIDS We shall then move on to examine a 
more comprehensive model as described by Blythe and Anderson (1988) [9] Finally 
we shall comment on the relevance of these models withm the Irish context
2.2 Prelim inary M odels
Some of the most comprehensive models to date are proposed by Anderson(1988) 
[2], Bailey(1988) [6] and Isham (1988a) [26] Anderson proposes a simple determin­
istic model representing a closed male homosexual population of size N This model 
consists of three compartments, the susceptible, denoted by X y infectious and dis­
eased (AIDS), denoted by Y  and A  respectively This is a closed community with 
no recruitments of susceptibles and no mortality other than those deaths from the 
disease AIDS We have
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^  =  A X - v Y  
dt
dA  v  a—— — v Y  — a  A
dt
d N
—r-  = —a A  
dt
(2 1)
with the following definitions,
A is the per capita force of infection, A = ¡3cY/N ,
/? is the probability of infecting a susceptible partner, 
c is the average number of sexual partners per unit time,
D  is the average duration of stay in Y, v = l / D  defines the rate of leaving the 
infected class Y  to join the AIDS class A  and 
a  is the rate of mortality in the AIDS class
HIV will persist once introduced into the community provided Ro > I where Ro 
defines the average number of secondary cases of infection generated by one primary 
case in a totally susceptible community For the model described above Ro = f3cD 
with the assumption that infectious individuals are infectious throughout their stay 
m the Y  class T hat is, the model assumes that the incubation period is the same 
as the infectious period
In the above it was assumed that individuals infected had constant mfectivity 
throughout the long incubation period Recent studies invalidate this assumption 
Anderson models for one hypothesis, the hypothesis tha t there are 2 phases of peak 
infectiousness In the intervening period between the peaks infectiousness may be 
very low or zero W ith this assumption Anderson constructs the following model, 
which is similar to the simple model described earlier but with extra compartments 




= X X  -  uoYi
I T  '
dYz 
d t




In the first phase the probability of infecting a susceptible partner is /3o In the 
second phase one is non infectious and in the third phase probability of infecting a 
susceptible partner is fa  In the above model we have
\  = c(PoYi+fi iY3 ) /N ,  (2 4)
where
N  = X  + Yx + Y2 + Yz + A  (2 5)
and c is the average number of sexual partners
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In summary Anderson says that the early exponential phase of the epidemic 
depends mainly on the first episode of infectiousness However both episodes are 
im portant in setting saturation levels later in the epidemic
Isham (1988a) [26] reviews some of the mathematical models currently in use 
In addition she also discusses the use of a deterministic model as opposed to  a 
stochastic one She says tha t, in general, for large populations, once the disease 
is established, the deterministic model should give solutions that are approximately 
valid In this paper Isham first discusses a simple model for the spread of HIV within 
a closed male homosexual community She then moves on to discuss a model which 
incorporates two classes, those who do and those who do not develop AIDS Finally 
she produces a model which involves heterogeneity in sexual activity
W ith a heterogeneous model the early exponential increase in the incidence of 
seropositivity or of AIDS is expected to be rapidly replaced by a more slowly in­
creasing function In the initial period the rapid spread of infection is through the 
highly active individuals but most of the subsequent infections will be from the less 
active individuals amongst whom the epidemic will progress at a slower rate An 
im portant point to note at this stage is that the slowing up in the rate of increase of 
the incidence is an inevitable consequence of heterogeneity and not a consequence of 
people changing their behaviour Thus in a highly promiscuous homosexual commu­
nity it may be reasonable to approximate the transmission probability per partner 
by a constant but it is less hkely to be appropriate for a population where long 
lasting partnerships are common This should be remembered in the context of the 
Irish male homosexual population where, due to legislation, homosexuals tend to 
have fewer partners
For transmission between heterosexuals Isham complicates her model further 
since there are now 2 groups of individuals with the infectives in one group spreading 
the infection to the susceptibles m the other Isham denotes the numbers of female 
susceptibles and infectives by x f  with x m (t), ym(t) being the corresponding
quantities for males In a 2 group analogue of the simple homogeneous mixing model 
the quantities satisfy the following
-  - 3 fk xm( t ) ^  
dt ~  P / *n  n f ( t )
d j ^ t )  = _ d ^ ) _ ym 
dt  dt  w
dt n m(t)
M i l  =
dt dt
(2 6)
Here mean incubation periods l / v m , l / v f  and the transmission coefficients 
for the spread of the infection from male to female and from female to male are 
not assumed to be the same Anderson and May (1988) [3] have suggested that 
P j <  j3m < /?, where /? is for homosexual men Similarly the rates of partner change 
km , k j  are probably not the same In the model given above only the spread of HIV 
is modelled To extend these equations to include the incidence of AIDS and of 
non infectious seropositivity together with immigration of susceptibles and natural 
mortality extra variables and parameters must be introduced
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2.3 B lythe and A nderson M odel
In this section we discuss a particular paper of Blythe and Anderson (1988) [9] and 
the use of the model they discuss in the context of the Irish situation We shall also 
briefly discuss the parameters of this model and shall give details on how we propose 
to obtain the data which will enable us to estimate these parameters
Blythe and Anderson derive from a series of risk or hazard functions distribu­
tions describing the variation in the infectious and incubation periods of the human 
immunodeficiency virus (HIV) Recent studies of the incubation period of AIDS in 
patients infected via blood transfusions and blood products reveal great variability 
among patients Current estimates of the incubation period range from 4 to 8 years 
The relationship between the incubation and infectious period is also uncertain but 
is taken by Blythe and Anderson to be of equal length Blythe and Anderson start 
with the development of a simple compartmental model which describes the trans­
mission dynamics of HIV within a male homosexual community The model is given 
in terms of a set of differential equations tha t describe changes in the number of 
persons in a series of classes which denote different states of susceptibikty and in­
fection This model was first proposed by Anderson et al (1986) [5] We have the 
following system,
With X(i) denoting the number of susceptibles, A(t) the number of AIDS patients
develop AIDS ( total Y ( t ) ), and i(ti, t) the number of infected and infectious persons
d X
dt
A - c \ X ( t ) - f i t X ( t ) , (2 7)
d y (u , t )  d y (u , t )  
dt du
d i (u , t )  d i (u , t )  
dt  du
-(i>y(u) + / i )y(u, t ) ,







V y ( t ) - ( d  + p)A(t) ,
(2 11)
(2 10)
with the following initial conditions,
X ( 0 )  =  A //X ,
2/(0,  t) = pcX( t)X(t)  + J( t ) ,  
1(0 ,0  =  (1 — p)cX(t)X( t) ,  
¿(0) = 0,
Z ( 0 ) = 0,






A(i) P X ( t )  + Y ( t )  + I( t)  + A ( t ) +  Z(i)  ’ (2 17)
(2 19)
(2 18)
and Z(t)  the number of post-infectious seropositives (from the non-AIDS stream) at 
time t y(u, t) denotes the number of infected and infectious persons who eventually
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who do not develop AIDS ( total I ( t )  ), who have been in their respective classes 
for the infinitesimal interval (u , u + du) at time t The parameters are as follows,
A > 0 is the recruitment rate,
fi > 0 is the normal per capita death rate,
A(i)c is the force of infection, where, c > 0 is a measure of sexual activity (new
partners per unit time),
P > 0 is the transmission coefficient, that is the average probability that an infected 
person will pass on the infection, per partner, 
d > 0 is the AIDS related death rate,
p  > 0 is the fraction of those infected who enter the Y ( t )  class (and hence the pre
AIDS stream,
1 -  p  is the remaining fraction who enter the I ( t )  class (and hence the non AIDS 
stream),
v y (u) , v i (u ) are the rates at which individuals of residence time u are removed by 
the development of AIDS or loss of infectiousness, respectively and 
Vy(/),V/(£) are the rates of recruitment of individuals to the AIDS and post infec­
tious classes respectively
We can solve equations (2 8) and (2 9) by using characteristic equations to give,
y (u , t )  =  y(0, i  -  u )e x p (- /i ti)e x p (-  /  v y ( u ,)duf), (2 20)
Jo
i (u , t )  = i(0, t — u)exp(—//u)exp( — I v j (u f)duf), (2 21)
Jo
We can then write equations (2 18) and (2 19) as,
W (i)  =  f  f Y { u ) e - ^ \ p c \ ( t - u ) X ( t - u )  + J ( t - u ) } d u  (2 22)
Jo
Vj( t )  = [  f i ( u ) e - ^ u[ ( l - p ) c X ( t ~ u ) X ( t ~ u ) - ^ J ( t - u ) ) d u  (2 23)
Jo
where
f Y (u) =  u y (u )ex p (- /  t>y(uf)duf) (2 24)
Jo
f j ( u )  -  v /(u )ex p (-  f  v i ( u ' )dur) (2 25)
Jo
We can now integrate over all u m equations (2 8) and (2 9) to obtain ordinary 
differential equation forms for pre-AIDS and non-AIDS populations, giving
^  =  p c \ ( t ) X ( t )  +  J ( t )  -  W ( i )  -  v Y ( t ) ,  (2 26)
^  =  (1 -  p)cX( t ) X( t )  -  V i Y { t )  -  n l ( t )  (2 27)
Equations (2 7), (2 10), (2 26) and (2 27) specify our distributed incubation period 
model for t > 0, with X (0 )  = A//x and Y ( 0) =  7(0) =  A{0) = Z ( 0) =  0 The 
functions /y (u )  and f i ( u )  are the probability density functions for the duration of 
the pre-AIDS class and non-AIDS class The quantities v y (u )  and vj(u)  are the risk 
or hazard functions and are related to f y ( u )  and f i ( u )  through equations (2 24) and 
(2 25)
Blythe and Anderson (1988) [9] then discuss four probability density functions 
and their underlying hazard functions These are the exponential, Weibull, Erlang
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and rectangular They also examine the steady state behaviour of the model given 
these distributions and find tha t the errors in X*, (the equilibrium point of the 
system), deriving from the use of different distributions around the same mean 
incubation period are negligible
We shall use the Blythe and Anderson model as a basis for our two population 
transmission model in Chapter 7 We shall see that in order to find actual estimates 
of the numbers HIV positive and with AIDS we need to simplify the existing model 
as proposed by these authors In Chapter 6 we shall discuss the param eters in more 
detail and shall provide estimates for these from our survey
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Chapter 3
E stim ating The Incidence of 
H IV  Infection using the Back 
P rojection  M ethod.
3.1 Introduction
The Department of Health m Ireland acts as the centre for the collation of na­
tional data on AIDS, with diagnosed cases being reported directly to the AIDS 
Co-ordinator A considerable time lag may occur between the time that a case is 
diagnosed and the time at which it is recorded m the national AIDS figures, (the 
difference between these times being known as the reporting delay) It is at the time 
of diagnosis and not the time of reporting that the patient will need treatment and 
it is therefore necessary to plan for and work with the number of diagnosed cases 
Recently Brookmeyer and Damiano (1989)[10] have described a method, based on 
the reporting delay distribution, for adjustment of the numbers of AIDS cases with 
respect to reporting delays, and we have adapted their method here for our investi­
gation of the Irish figures
Knowledge of the numbers infected with the HIV virus and of the incubation 
period distribution allow us to predict the number of AIDS cases we can expect in 
the future from these HIV patients Similarly, if the number of AIDS cases (after 
adjustment for reporting delays) is known and information on the incubation period 
distribution is available, we may derive estimates for those previously infected with 
the HIV virus This method is known as back-projection It must be stressed, 
however, that since the proportion of those infected who eventually go on to develop 
AIDS is unknown, and as we are working from the number of diagnosed AIDS cases, 
this method provides estimates only for those infected who will eventually go on to 
develop the disease
The relationship between the incidence of AIDS cases, the incidence of HIV in­
fections and the distribution of the incubation period is well documented by Brook­
meyer and Gail (1986), (1987), (1988),[13,12,11], Isham (1988)[25] and Anderson 
(1989)[1] and may be expressed in the form,
a(t) -  \  h(t -  u ) f ( u ) d u , (3 1)
Jo
where a(*) is the rate of new diagnoses of AIDS cases, h(t)  is the rate of acquiring 
HIV infection and f ( t )  is the distribution of the incubation period Intuitively, if
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we take t in years, equation (3.1) above says that the number of AIDS cases to be 
diagnosed in any one year arises via the incubation period distribution from the 
number of HIV infecteds in all previous years back to the start of the epidemic.
3.2 A djusting the number o f diagnosed AIDS cases for 
reporting delays.
For every AIDS case reported, data is supplied on the risk group (and other demo­
graphic features) of the patient and the date that he/she was diagnosed as falling 
within the CDC definition of an AIDS case. The CDC classifies those with the HIV 
virus into four groups. Group I, seroconversion; Group II, asymptomatic; Group 
III, progressive generalised lymphadenopathy and Group IV, patients with clinical 
manifestations of HIV infection designated by assignment to one or more subgroups 
(A-E). Within Group IV, subgroup classification is independent of the presence or 
absence of lymphadenopath. Subgroup IV C l defines an AIDS case. It consists of 
patients with secondary infectious diseases defined as the diagnosis of an infectious 
disease associated with HIV infection and/or at least moderately indicative of a de­
fect in cell-mediated immunity. Included are patients with symptomatic or invasive 
disease due to one of a number of specified secondary infectious diseases.
Reporting delays may occur for a variety of reasons, such as pressure of work or 
delay for the accumulation of several cases. Typically, figures for any quarter will not 
be completed for anything from one to forty two months due to reporting delays. 
Demands for services provided in the form of special care or hospital resources, 
for example, may well be immediate. In the most recent Department of Health 
reports the total number of cases diagnosed to date will clearly not be known due 
to reporting delays. Predictions however must ideally be based on the numbers of 
diagnosed cases and we must therefore adjust the number of diagnosed cases to take 
account of the time lag.
The problem of reporting delays is discussed by Brookmeyer and Daminano
(1989)[10], who base their method on a conditional likelihood for estimation of the 
reporting delay distribution. Calendar time is divided into intervals defined by the 
calendar dates,
T0 , T i , . . .  , 7 /* ,
i.e. the j th calendar interval is
[7j-i ? 7j), j  = l , . . . , i£ .
Tr  is the most recent report date. Reporting delays are classified into intervals 
[d ,_i,dt), i = 1 For each case we know the date of diagnosis and the date of 
the report. AIDS cases are cross classified by their date of diagnosis and the length 
of their reporting delay. Brookmeyer and Damiano essentially define a matrix with 
rows and columns equal to reporting delays and date of diagnosis respectively with 
elements equal to the numbers of AIDS cases. This procedure may be modified to 
be used with the data of a single risk group where appropriate but since numbers 
in any particular risk group are small for Irish data, we concentrate on the general 
approach.
Wc let Xij  represent the number of AIDS cases diagnosed in the j th  calendar 
interval [ T j - \ ,T j )  who had a reporting delay in the interval [dt_ i,d x) , i = 1 
We must remember that we may not have all the information on Xij .  For a given j
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we have complete information on X l3 if
1 < * < Lj, 
where L 2 is the largest value of i such that
T j + < Tr
The total number of cases diagnosed in the j t h  interval who were reported at or 
before the report date Tr , is
h
* ,  = X X  (3 2 )
»=1
We are interested in estimating the reporting delay distribution 
Let px represent the probability that an AIDS case has a reporting delay in the 
interval [dt- \ , d x) Thus the reporting delay distribution p = 0 >i,P2,P3, ,Pi}  
refers to cases which are reported with delays less than or equal to dj  For each 
j  the observed counts X lt7, when conditioned on the total X  j have a multinomial 
distribution with sample size X  3 and cell probabilities
Ptj = Pi = , L } (3 3)
:=1
The conditional likelihood for { X l3, i  = 1, = 1, , R }  conditional on
f c - n  j t f r ,  <34,
3=1 1 l t= lA *J *=1
This likelihood function is the same as the joint probability density function of 
the response variables X %3, but viewed primarily as a function of the parameters, 
pt , conditional on the observations A computational advantage of L c is that we 
can use GLIM [41] to estimate the parameters by declaring to have a Poisson 
distribution with mean exp(a, +  p: ), (Poisson error, log link) Once the maximum 
likelihoods of the parameters a x and f33 are found the estimate of pt is given by
p, =  ea ' \ £ e a ' (3 5)
Details of the method given in Brookmeyer and Damiano (1989) [10] describe the 
use of the estimated reporting delay distribution p to adjust the observed numbers 
of diagnosed AIDS cases In practice the number actually diagnosed in the interval 
of calendar time (Tr  -  dmyTR — dm_i) is found by multiplying the reported number
diagnosed in this interval by the factor [ l ^ T 1 P* +  Prn/^]
3.3 The M ethod of Back-projection.
The method of back calculating from British and American AIDS incidence data 
has been discussed by Anderson (1989) [1], Brookmeyer and Damiano (1989) [10] 
and Isham (1988) [25] New cases of HIV are assumed to occur in a Poisson process 
denoted h(t) The lengths of the incubation periods (l e the time between infec­
tion with the HIV virus and diagnosis of AIDS) are considered to be independent 
identically distributed variables with probability density function /  New cases of
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diagnosis o f A IDS then occur in  a Poisson process rate a ( t ) y given by equation (3 1) 
above I f  we know any two o f a ( i) ,  h(t )  or f ( t )  then the th ird  can be derived
I t  has been shown by Downs et al (1987) [20] th a t in  Europe the numbers of 
new A IDS cases grew rap id ly  m the early years o f the epidemic T h is  has since been 
followed by a period o f slower grow th w ith  doubling tim es increasing To describe 
the rate o f new diagnosis o f A ID S  cases we consider fou r form s for a(t )  We have,
a(t )  = doex p( d i t )  (3 6)
a (t)  =  a o e x p (a ii -  a 2t2) (3 7)
a(t )  =  (b0 +  b i t ) /  e x p ( l -  t)  +  b2 (3 8)
a(t )  =  co +  cxt +  c2t 2 (3 9)
These four reflect em pirica l results which suggest tha t an in it ia l period o f exponentia l 
grow th  in  A IDS cases is followed by a period where grow th is slower S im ila r a(t )  
have been employed by Isham (1988) [25] in  her work on the U K  figures We choose 
these not to  model the fu tu re  incidence o f A ID S  cases bu t ra ther to  model over the 
range o f values for which we wish to  estim ate k(t )
The gamma and W eibu ll d is tribu tions  have been used to  model the incubation 
period d is tribu tion , as suggested by B ly the  and Anderson (1988) [9] and Medley 
et al (1987) [35] The gamma d is tr ib u tio n  we denote by T (a ,A )  w ith  p ro bab ility  
density function,
/ ( / )  -  X(Xt)a~1 exp(-A i)/r(a), (3 10)
w ith  t >  0 and mean =  a / X  The W eibu ll we denote by W (/?,/>) w ith  p ro bab ility  
density,
f ( t )  =  e x p {—(pi)*3} ,  (3 11)
fo r t  >  0 and mean / i =  />-1 T ( l  - f 1 / 0 )
I f  a(t)  is given by equations (3 6 )  to  (3 9) and f ( t ) is the gam ma d is tr ib u tio n  
then h(t )  can be determ ined ana ly tica lly
Consider the case where f ( t )  is given by T (2 ,A ), we then have,
a(t )  ~  !  h(t  -  u)X2u e x p ( - X u ) d u  (3 12)
Jo
To solve this in tegral for h(t)  we make a change o f variables Let s =  t -  u, when 
u =  0, s =  t and when u =  £, s =  0 We also have ~ d s  =  du S ubstitu ting  these 
in to  the above gives,
a(t)  =  f  h(s)X2(t -  s ) e x p ( - X ( t  — s) )ds  (3 13)
Jo
Using Le ibn itz ’s rule for the derivative o f an in tegra l gives us,
=  f  h(s)X2(t -  s ) ( -A )e x p (~ A ( i -  s))  - f h ( s ) \ 2 e x p ( - \ ( t  -  s ) )ds  (3 14) 
at Jo
D iffe ren tia ting  a second tim e, d iv id ing  across by A2 and rearranging gives,
1 d2a f*
**(*) = ¿2 ¿¡2 + J0 - ^ 2M 5) ( * - 5) ex p ( “ A ( * - s ) )  + 2 A / i( s )e x p ( -A ( / - s ) )d 6  (3 15)
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h{ t )  =  ^ - a { t ) + [ T t + X a { t ) } l  (316)
and adding the coefficients of a(t) gives,
, , v 1 d2a 2 da , . , n -
h ( t ) = v i f i  + \ t i +a(t) (317)
Using the same approach we can show tha t for f ( t )  =  T (l, A) we have,
h(t) = j %  + <t )  (3 18)
For f ( t )  = r(3 ,A ) we have,
, . . 1 d3a 3 d2a 3 da N
h { t ) =  V d f i  + + X d i  + a( t )  (319)
while for f ( t ) =  T(4, A) we have,
f 1 d4a 4 d3a 6 (Pa 4 da
K t ) =  \ * d i * + V d i 3  + V d t i + Adi + a ( i )  (3 20)
From equations (3 17) to (3 20) we see tha t the order of h(t)  is given by the value 
of a  and the coefficients of h(t)  are binomial in form
If we choose to use the Weibull distribution to model the incubation period 
than analytical determination of h(t)  is not possible as we require the integral of 
a quadratic exponential Equation (3 1) must be solved numerically, to do this we 
again make a change of variables by letting $ = i — u For f ( t )  = W ( 2 ,p )  this gives
a(i) =  /  h(s)2p2(t -  s ) e x p ( - p 2(t -  s )2), (3 21)
Jo
a linear Volterra equation of the first kind Equation (3 21) may be viewed as 
the convolution of h(t)  and /(£), which could be solved using Laplace transforms 
This would then require finding the Laplace transform of a (i), this however cannot 
be derived analytically when a(t) is given by equation (3 7) Alternatively if we 
differentiate equation (3 21) twice this gives,
1 d2n r1
= Jo ~ +  4 p ~ ■s)3]exP(~/!,2(< “  s f )h( s )ds  + h(t) (3 22)
This integral equation is now a Volterra equation of the second kind The NAG 
(1984) [38] library of routines can then be used to numerically solve the integral 
equation We choose routine D05ABF, which solves Fredholm equations of the 
second kind (similar to Volterra equations but with fixed limits of integration) by 
finding an approximation to the solution in the form of a Chebyshev series, as 
described by El-gendi (1969) [21]
3.4 R esu lts
Our analysis was based on cases reported to the Department of Health up to March 
1990 We decided to look at the reporting delays m all cases diagnosed up to the
From equation (3 14) above we have,
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31st of December 1989. As of 31st of March 1990 131 cases of AIDS had been 
reported to the Department. Of these 4 were diagnosed in 1990 and two cases were 
incorrectly recorded. This left 125 diagnosed AIDS cases up to the end of December 
1989. The case number, date of diagnosis and date of report was recorded for each 
of the 125 cases. The reporting delay and the dates of diagnosis were grouped into 
three month intervals. The first case of AIDS was diagnosed in 1980. No cases were 
diagnosed in 1981 and the second Irish case of AIDS was diagnosed in late 1982. 
For ease of manipulation we assumed that the first case of AIDS occurred in 1981. 
As data was grouped into three month intervals we had delays of up to fourteen 
quarters (maximum delay was forty two months). All cases from the third quarter 
of 1986 were adjusted by multiplying the reported numbers of diagnosed cases in 
that quarter by the appropriate factor. For example cases in the first quarter of 
interest (1986, third quarter) were multiplied by 1.004. The number of cases in the 
second quarter was multiplied by 1.012 and so on until the number of cases in the 
final quarter (the thirteenth) was multiplied by 1.232. Table 3.1 shows the reporting 
delay probabilities when the model E(Y{j)  =  exp(at + fij) was fitted to the data 
using GLIM [41].
TABLE 3.1 
Estimated Reporting Delay Probabilities.
Delay(months) Pi £  Pi
0 - 3 0.776 0.776
4 - 6 0.072 0.848
7 - 9 0.048 0.896
10 - 12 0.056 0.952
13 - 15 0.016 0.968
16 - 18 0.008 0.976
1 9 -2 1 0.000 0.976
2 2 -2 4 0.000 0.976
25 - 27 0.000 0.976
28 - 30 0.000 0.976
31 - 33 0.000 0.976
34 - 36 0.008 0.984
37- 39 0.008 0.992
40 - 42 0.008 1.000
It is interesting to note that almost 85% of all cases are reported within six 
months of diagnosis. This is due to the fact that most cases appear in the Dublin 
genito urinary clinics and are reported almost immediately. Brookmeyer and Dami- 
ano (1989) [10] in their work on the United States data show that 78.9% of all cases 
are reported within six months of diagnosis and 88.9% are reported within a year. 
We see also that there has been up to a 42 month reporting delay in the Irish data, 
this was a case that was diagnosed early in the epidemic. A maximum delay of 48 
months is reported in the U.S. data.
As cases are reported promptly and numbers are small, very little adjustment 
was made to the quarterly figures. There were no differences in the reported numbers 
of diagnosed cases and the adjusted numbers of cases for 1981 to 1988. There was 
a difference of plus four cases between the reported and adjusted numbers for 1989. 
The adjusted numbers of cases is provided in Table 3.3.
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The functions (3 6) to (3 9 ) which describe the rate of appearance of new AIDS 
cases were then fitted to  the adjusted AIDS incidence data for 1981 to 1989 The 
parameter estimates along with R 2 (a crude measure of how well the regression 
equation fits the data, with 100% indicating a perfect fit R 2 = 100(SS due to 
regression)/(SS total)) are given below in Table 3 2
J
TABLE 3 2
Param eter estimates obtained for a(t)
Exponential do =  0 336 dl = 0 558 R 2 =  94 4%
Quadratic
R 2 = 96 4%Exponential a0 = 0 573 ai = 0 267 a2 = - 0  029
Linear
Logistic b0 = 0 145 bi = - 0  014 ¿2 =  0 658 R 2 =  98 9%
Quadratic c0 =  10 905 Cl = - 8  465 c2 = 1 445 R 2 = 97 6%
The expected annual AIDS incidence these parameters give rise to is given m 
Table 3 3
TABLE 3 3





Quadratic Observed Cases 
(Adjusted)
1981 0 59 0 77 0 79 3 88 1
1982 103 1 10 0 98 -0 25 1
1983 1 79 1 66 1 41 -149 1
1984 3 14 2 66 2 43 0 16 3
1985 5 48 4 52 4 70 4 70 6
1986 9 57 813 9 53 12 13 6
1987 16 72 15 50 19 05 22 45 22
1988 29 21 3134 35 09 35 65 35
1989 51 04 67 14 51 93 51 75 54
Isham (1988) [25] cites work done by Anderson and Medley (1988) [4] on mod­
elling the incubation period distribution They fitted both the gamma and Weibull 
distributions given by equations (3 10) and (3 11) to data  from transfusion recipients 
available up to April 1988 and obtained the following parameter estimates, T(a, A) 
a  = 2 70, A = 0 19 with mean p  = 14 3 years W(f3,p)  j3 = 2 33, p =  0 12 with 
mean p  = 7 3 years
For ease of manipulation we have solved above for h(t),  when f ( t )  is given by 
the gamma distribution with a  =2 or 3 and the Weibull distribution with ¡3 = 2 
Since exact progression rates are unknown, we choose to work with a spread of 
three different progression rates to estimate rate of new cases of infection, h(t) slow 
progression given by T(3,0 21), mean incubation period p  = 14 3 years, 38% of 
all infected individuals progress to the disease after 10 years, moderate progression 
given by T(2,0 14), mean incubation period, p  =  14 3 years, 44% progress after 10 
years and rapid progression given by W (2, 0 12), mean incubation period, p  = 7 4 
years, 79% progress to the disease after 10 years A comparison of these assumed 
progression rates with those fitted by Anderson and Medley (1988)[4] can be seen 
m Figure 3 1 and Figure 3 2
For each of the four choices of a(i) and using equations (3 17) and (3 19) and using 
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the expected annual incidence of HIV infections given each of the three progression 
rates. Expected annual incidence of HIV infection given slow progression is provided 
in Table 3.4. Expected annual incidence given moderate and rapid progression is 
provided in Tables 3.5 and 3.6 respectively. In addition the cumulative numbers 
infected given certain conditions (described in the footnotes at the bottom of Tables 
3.4, 3.5 and 3.6) up to the end of 1989 are provided.
TABLE 3.4
Expected annual incidence of HIV infections given slow progression rates, 






1981 29 21 19 121
1982 51 42 43 158
1983 88 89 96 198
1984 154 189 204 241
1985 269 413 405 287
1986 470 937 697 336
1987 821 2206 795 388
1988 1434 5413 -822 442
1989 2506 13876 -10343 499
1990 4380 37244 -50157 560
1991 7654 104831 -196255 623
1992 13377 309834 -696336 689
Total to 
1989 5822 23186 38491 2670
1 Assuming 795 cases in 1988 and in 1989.
TABLE 3.5
Expected annual incidence of HIV infections given moderate progression rates, 






1981 15 11 8 72
1982 26 19 18 109
1983 45 34 42 149
1984 79 64 93 192
1985 137 126 200 238
1986 239 262 403 287
1987 417 571 713 338
1988 729 1311 904 393
1989 1274 3168 -351 450
1990 2226 8063 -8589 511
1991 3890 21625 -44096 574
1992 6799 61146 -176269 640
Total to 
1989 2961 5566 32851 2228
1 Assuming 904 cases in 1989.
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TABLE 3.6
Expected annual incidence of HIV infections given rapid progression rates, 






1981 7 5 4 105
1982 12 9 9 116
1983 22 16 20 131
1984 37 30 43 144
1985 61 59 85 152
1986 102 119 153 156
1987 172 259 222 159
1988 297 601 96 162
1989 520 1486 -1107 166
1990 917 3880 -6771 171
1991 1621 10655 -28775 178
1992 2861 30730 -106656 184
Total to 
1989 1230 2580 9801 1286
1 Assuming 222 cases in 1988 and in 1989.
3.5 Discussion
We see from Tables 3.4, 3.5 and 3.6 that the estimated total number of individuals 
infected with the HIV virus from 1st January 1981 to 31st December 1989 ranges 
from 980 to 23186 depending on the assumptions made about a(t) and f ( t ) .  This 
is not surprising, as a wide interval is inevitable given the amount of data we are 
working with. Isham (1988) [25] in her work on applying the back projection method 
to HIV cases in the United Kingdom estimates between 19,578 and 60,269 cases of 
the virus between 1980 and 1887 inclusive. Some further comments are discussed 
below in explanation of the seemingly wide interval in the Irish data.
Describing a(i) by an exponential gives totals of 5822, 2961 and 1230 cases of 
the HIV virus in Ireland up to the end of 1989, given slow moderate and rapid 
progression rates respectively. After 1989 there is a large increase in the predictions 
for the numbers HIV positive. This would seem to imply that the plateau phase 
following exponential growth that A.M. Downs et al (1987) [20] speak of starts at 
the beginning of 1990 in the Irish case. This is a reasonable assumption as first cases 
of AIDS in Ireland were not identified until the early to mid eighties, as opposed to 
some other European countries where first cases were identified in the late seventies 
and early eighties.
Describing a(i) by a quadratic exponential gives a large increase in the fitted 
values for the number of AIDS cases between 1988 and 1989. This is then reflected 
in the predictions for the HIV figures from 1988 to 1992, (illustrated in Table 3.4 
where the predicted annual incidence given slow progression for 1988 is 5413 cases 
and 13,876 cases in 1989). We have said earlier that the experiences of other countries 
suggest that the epidemic reaches a plateau after the initial phase of exponential 
growth (Downs et al (1987) [20]). If then, we assume approximately the same 
number of individuals infected in 1989 as in 1988, then a total of 14,723 cases will 
be observed given slow progression rates, giving an overall interval of 980 to 14,723
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HIV cases in Ireland from 1981 to 1989 inclusive This is a reasonable assumption 
as we know from test centres in Ireland that we had an increase of 229 in the known 
numbers of HIV positive cases in 1986, 143 in 1987, 116 in 1988 and an increase of 
116 cases again m 1989
Also, slow progression assumes that only 38% of all individuals infected with 
the virus progress to the disease after ten years Consequently this progression rate 
will predict tha t the current AIDS cases came from a large pool of HIV infected 
individuals
Looking at moderate and rapid progression rates with a(£) described by the 
quadratic exponential we note that the total number of HIV infected individuals up 
to 31st December 1989 are 5566 and 2580 respectively These would appear to be far 
more realistic figures given that we know from Irish testing centres that we have at 
least 910 individuals infected at this time Again however there are large increases 
in the predictions for 1990, 1991 and 1992 As more data  on the numbers of AIDS 
cases and reporting delays becomes available these projections can be re-estimated 
based on the new estimates for a(t)
The linear logistic form for a(t) gives negative values for h(t)  in later years This 
problem was also encountered by Isham (1988) [25] m her analysis of the U K data 
Although the linear logistic describes the number of AIDS cases well over the years 
1981 to 1989, it predicts low values for a(t)  in later years as can be seen in Table 
3 3 This is then reflected in the predictions for h(t)  given m Tables 3 4,3 5 and 3 6 
However, on the basis of the known increases in the numbers of HIV cases given 
above, we can make the assumption that we have at least the same number of HIV 
cases m 1988 and 1989 as predicted in 1987 for slow and rapid progression and at 
least the same number of cases in 1989 as we had in 1988 for moderate progression 
then we arrive at estimates of 3849, 3285 and 980 cases for slow, moderate and rapid 
progression respectively
The figure of 980 cases with rapid progression still appears to be unreahstically 
low This may be explained by the fact that with rapid progression rates we are 
assuming that 79% of all infected individuals progress to the disease within ten years 
This low prediction of HIV cases may also reflect the extent of under reporting of 
AIDS cases
Finally the quadratic form for a(t) provides estimates of 2670, 2228 and 1286 
cases up to 1989 for slow, moderate and rapid progression rates These figures are 
encouragingly similar to those predictions of HIV arising from both the linear logistic 
and exponential forms of a(i)
For planning purposes it would seem prudent to assume the moderate progression 
rates of 44% progressing to the disease withm ten years This would then give 
estimates of 2961, 5566, 3285 and 2228 individuals infected with the HIV virus in 
Ireland as of 31st December 1989 given each of the four forms for a(t) However it 
must be stressed that, as yet, exact progression rates are unknown and as such all 
estimates should be viewed with caution Further research into this area of modelling 
the disease is imperative if reliable estimates for h(t)  are to be provided
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Chapter 4
Im proved E stim ates of the  
Incidence o f H IV  Infection.
4.1 Introduction
We saw in Chapter 3 how estimates of the incidence of HIV infection were provided 
A method known as ‘Back-Projection’ was employed to predict annual incidence of 
HIV infection This method is based upon the knowledge of the distribution of AIDS 
cases and the distribution of the incubation period We provided estimates for the 
level of HIV infection from 1981 to 1989 given slow, moderate and rapid progression 
rates from HIV infection to the onset of AIDS
The time taken to  progress from infection to disease is known as the incubation 
period Much work has been carried out in the United Kingdom by Anderson and 
Medley (1988) [4] on the study of the incubation period distribution We have seen 
in the Anderson and Medley work that the distribution is well described by a gamma 
distribution with a mean of 14 3 years and 48% of all those infected progressing to 
AIDS within 10 years In this chapter we shall implement their exact choice of 
incubation distribution into our integral equation model for back projection and 
in so doing we shall considerably improve our estimates of the incidence of HIV 
infection in Ireland from 1981 to 1989
4.2 M ethods
We have seen that the integral equation model arising m Back-Projection is a linear 
Volterra equation of the first kind with a difference kernel We have
a(t) = f  h(t -  u ) f ( u )d u  (4 1)
Jo
When / ( / )  is given by a gamma distribution with parameter a  £ R  as opposed to 
a  € N  in the previous chapter, then equation (4 1) becomes increasingly difficult to 
solve Although (4 1) may be viewed as the convolution of h(t)  and f ( t )  we cannot 
find a solution by means of inverse Laplace transforms
We show how (4 1) can be changed into an generalised Abel integral equation by 
differentiation The solution of this equation is then given in terms of an integral in 
the two known functions a(i) and f ( t )  We then proceed to solve the the resulting 
integral in terms of incomplete and complete gamma functions We also provide 
error bounds for all solutions
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4.3 E xponential G rowth in A ID S Cases.
We shall first consider the solution of (4 1) given exponential growth m the number 
of AIDS cases We have seen in Chapter three that the exponential model fits the 
Irish data well We have
a(i) =  doexp(dit) (4 2)
and
/ ( i ) = r ^ ta" lexp(- At)’ (43)
with 2 < a  < 3 Substituting (4 3) into (4 1) and making the change of variable 
t -  u = s gives
a(t)  =  ^  ~ s )“_1 exP(~*(< -  s))ds (4 4)
Differentiating with respect to t gives
a { t )  =
+ h (s ) ~ - ! ) ( < -  •s)“-2 exp(-A (i -  s))ds,  (4 5)
which can be rearranged to give
a(f) =  -A a(t)  +  f  -  l) ( i -  s)a~2 exp(-A(* -  s))ds (4 6)
Jo 1 (a )
Differentiating with respect to t a second time gives
f
a(t) = -Aa(i) + jf h { s ) ^ r ^ ( a - l ) ( t - s ) a- 2( - \ ) e x p ( - \ ( t - s ) )
+ k{s)f(a){a ~ ^  “  ,S^ _3exP(_ -  s))ci'9> (4 7)
which we can rearrange to give
Aa
a(t) + 2Aa(£) +  A2a(i) = p ^ y ( a  ~ 2)(a  — l)e x p (—At)
f  h(s)( t  -  s )a~z ex.p(\s)ds  (4 8)
Jo
Letting 1/C  = A0f(a  — 2)(a  — l ) / r ( a )  and a  — 3 =  — p  gives
C exp(Al)[o(t) + 2Xa(t) + X2a(t)] = f  -xp~ ^ ds, (4 9)
Jo (l — ¿)P
where 0 < p < 1 Equation (4 9) is now a generalised Abel integral equation of the 
form
with U(s) as the required unknown
« “ I
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The solution of (4 10) is well documented A J Jerri (1985) [27, pages 82-87] in 
his book ‘Integral Equations with Applications’ discusses generalised Abel integral 
equations the solution of which is given by
m  =  S- ^ l ~  J \ t  -  s y - ' F ( s ) d s  (4 11)
We can now say that the solution of (4 9) is given by
h(t) = gm ^ ?r- exp(-A t ) ^ -  f  (t -  $)p_1 F(s)ds  (4 12)
7T at Jo
where
F( t)  = C  exp(A/)[a(i) -f 2Aa(/) +  A2a(i)] (4 13)
When a(t)  is given by the simple exponential in (4 2) we have
F (s )  = Cexp(Xs)[dod\  exp(dis) +  2Xdod\ exp(d is )  +  A2do exp(dis)] (4 14)
which when adding the coefficients and combining the exponentials gives
F(s )  = Cgexp[(dx +  A )$], (4 15)
with
g = dod\ +  2XdQd\ -f A2do (4 16)
We can now say that the required solution of h(t)  is given by
h(t)  =  C g 3171^ ] . eXp ( - Xt)^~ f  (t -  s )p_1 exp[(A + di)s]ds (4 17)
7r at Jo
and we wish to solve the integral on the right hand side of (4 17)
We have (
1 =  f  ( t -  s Y - 1 exp [(A + dx)s]ds (4 18)
Jo
where - 1  < p — 1 < 0  Let u  = t -  s when s — 0, u = t and when s = t ,u  = 0 also 
—du = ds Then we obtain
I  = exp[(A + di)t] f  up~ l exp[-(A -f d\)u]du  (4 19)
Jo
Making a further change of variables by lettmg v — (A +  d\ )u  gives
7 = e x (A + d ,> w  r iv-  e* * - v)dv’ (42°)
which we can write as,
r o o  ro o
I vp~l exp(—v)dv — I r p_1 exp(—v)dv  
Jo JiA+di )t
__ exp [(A -|- dx)t]
(A-Mi)p 
We can now say that
(4 21)
r
1 = -  r b ’ ( a + ^  ( 4  2 2 )
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We are required to find d l / d t  This we can compute using Leibnitz’s rule for the 
derivative of an integral in order to find the derivative of the incomplete gamma 
function r[p,(A + d\)t] We have,
ri d r°°
= -(A  + di)p<p- 1e-(A+,il)‘ (4 23)
We can now say that
£  -  -q+d.u r (P) I fv-i r[p, (A+ dj)»(*+*)«
dt ~  (A + dj)»-! + (A + dj)P-i
= e(*+dl)(^ ( P l __  + tp-i  _ R  (424)
where „(A+cii )t
R = T\P,(X + d1)t}{x + - y ZT (4 25)
We can easily compute T(p) numerically and Olver (1974) [40, pages 66-67] provides 
us with bounds for T (z , t )  when z  < 1 and t > 0 We have
r[p,(A + di)t] < exp[—(A + di)i](A + di)p~l tp~l , (4 26)
as p < 1 and (A -f- d\) t  > 0 We have then from (4 17), (4 24) and (4 26)
R  < tp~ l (4 27)
and
h(t) = C g S^ f ^ - e - Xt [e(X+^ - (A+r y )p— + i"'1] -  R,  (4 28)
where
0 < R <  C g Stn^  e - Xttf ' 1 (4 29)
7T
In our results section we shall compute all constants and provide a table of estimates 
for /i(Z), the number of HIV cases in Ireland in year t, based on equations (4 28) 
and (4 29) above
4.4 Quadratic E xponential Growth in AIDS Cases.
Our objective in this section is to solve the integral equation (4 1) when a(t)  is of 
the form
a(t) = a0 exp (a it -  a2t2) (4 30)
and f ( t )  is given by the gamma distribution as previously with 2 < a  < 3 To do 
this we proceed as in section 4 3 and change (4 1) into a generalised Abel equation 
the solution of which is given by
stn(pir)n^i) =
where
h(  *t w W exp(-A t ) T  f  (t  -  s f ~ 1F{s)ds  (4 31)
7T at Jo
F(t)  =  C  exp(At)[a(t) -f 2Aa(t) +  A2a(t)] (4 32)
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and C  = T (a)/A (a)(a  -  2)(a  -  1) as previously W ith a(t)  given by (4 29) we can 
write
F( t)  =  C  exp(Ai )[4a3i2 + (4aia3 +  4Aa3)i -f (a j + 2a3 -|- 2 -f A2)]ao exp(ait +  a3i 2),
' (4 32)
where we write 03 = —a2 for convenience Letting
04 -  4aoa§,
«5 =  ao(4aia3 + 4Aa3)
oq = <io(a i +  203 + 2Aaj +  A2) 
and combining the exponentials gives
F(t)  = C(a4t2 +  a5t +  a6)exp[(a! +  A)t + a3*2] (4 33)
Completing the square on the exponential gives
■^(0 = C (a4tJ + a5i + a6)ezp[a3(f +  —)2]exp[-a3( - 7r—- ) 2] < (4 34)
2fl3 2a3
Writing S = (aj + A)/2a3 gives
F(t)  = C(a4t2 +  a5t -|- a6)exp[a3(t + S)2] ex p [-a 3i 2] t (4 35) 
From equation (4 30) we can now say that
h(t)  = C exp[-fl3^2]gm ^ r} exp(-A t)JT
Jo ^  ”  s ^ ~ l ^aAs2 + as$ + fl6)eaEMfl3(i  +  6) 7]ds (4 36)
We now wish to evaluate the integral on the right hand side of (4 36) above 
To do this we make the change of variable v = s + 6 Substituting into the integral 
above gives
I ( t )  = /  (t -  V + ¿)P'M “<(«> -  ¿)2 + o5(r  -  Î)  + a6]e031' dv (4 37)
J 6
I ( t )  =  I (i -  r  + ¿)p~ l[a4v2 -f (a5 -  2a4S)v  -f (a4S2 -  asS + ae)]ea3V dv (4 38)
Jo
ft+5 _
I ( t )  = / (* -  V + ¿ ^ “ '(ay t;2 + a8v +  09)ea3V dv  (4 39)
j s
• t + 5
'
Expanding (v -  ¿)2 and adding coefficients gives
■i+£
’5
Writing a 7 =  a4,ag = (05 -  2a4S) and a$ =  (a462 -  a$6 +  a6 ) gives
»i fi
*6
As we have a squared term in the exponential component of the integral above we 
cannot proceed as we did in the previous case Instead we choose to evaluate the 
above integral I ( t )  b> numerical means To do this we employ the NAG [38] library 
routine D01AJF, a general purpose integrator which calculates an approximation to 
the integral of the function F ( x )  over a finite integral (A, B)  This provides us with 
I ( t )  evaluated at the points of interest to us We shall provide the results from this 
routine below
In order to estimate h(t) we see from equation (4 37) tha t we require d l /d t  Using 
results obtained for I ( t )  from the integration above we shall proceed to numerically 
differentiate I ( t )  at the required points We first employ a forward-difference formula 
discussed in Burden and Faires (1985) [14, pages 136-141] to estimate d l /d t  for 
t 6 [1,12], the times of interest here We have
dl(tp)  _  I(tp +  h) -  I(tp) (4 41)
dt h
For small values of /i, the difference quotient [I(to +  h) -  I (to)] /h  can be used 
to approximate d l ( t 0) /d t  with an error of order h This formula is known as a 
forward-difference formula if h > 0 We then compare these results for d l /d t  with 
those obtained by the central difference formula
dl j to )  /(to  + h ) ~  I(to -  h) 
dt 2 h ( ’
which has an error of order h2 To assess the accuracy of results we then compare 
the output from the two methods with a small step size h The values derived for 
d l / d t  using this method will then be used to obtain estimates for h(t) The results 
obtained are given in Tables 4 3 to 4 5 m section 4 7
4.5 Linear Logistic Growth in AIDS Cases.
We now consider the solution of (4 1) when the growth in AIDS cases is given by 
the linear logistic function
^  = ; ^ 7 ) +6’ <443>
To do this we again change (4 1) into a generalised Abel integral equation, the
solution of which is given by (4 12) where F(s)  is now given by
F ( s ) = C exp(As){[(l + A)260 +  2(1 -j- X)b\ +  (1 +  A)2&ii]e 1e3 -f A2^ }  (4 44)
The required solution h(t) is now given by
h(t) = C e x p ( - A i ) ^ ^ ^ —  (4 45)
7T at
where
I  = f  (t -  s)p 1 exp(As)[(a +  bs)e l es +  A2b2\ds, (4 46)
Jo
with 63 = (1 +  A)250 -I- 2(1 -f A)b\ and 64 =  (1 +  A)26i For ease of manipulation we 
split /  into /  = I\  +  I 2 + h  with
Ix = f  (t -  s)p 1 exp(\s)bze  1e*ds,
Jo
h  = f  (t — s)1*“1 exp ( \ s )b 4s e “l e*ds1
Jo
I3 = f  (t -  5)p_1 exp(\s)\2b2ds
Jo
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Returning to / i ,  we make the change of variables u — t -  s Then when s = t, u — 0 
and when s = 0 ,u  = t and - d u  — ds Substituting into I \  gives
J 1 = f  up_1e x p [-( l -f A)u]du (4 47)
Jo
Making a further change of variables v = (1 +  X)u gives
h  =  - M L _ e < 1 + A >‘ / '  '
(i + a)p y0
^ £ L » ( 1+ A ) t ( r ( p )  _  r ( p >  ( 1  +  A )< ) ]  ( 4  4 8 )
(1 +  A )p
Differentiating Jj with respect to t and rearranging gives,
d h  636-1 T r(p )e( ^ > ‘ +  63e- 1<"-1 -  r [p ,( l  +  A)^ - ^36: ’ Te(1+A)i




T r(p)e(1+>)‘ +  fiae- 1«”- 1 -  J llf (4 49)
R1 = r[p,(l + (4 50)
But we know from (4 26) that
r(p ,(l + A)i) < e x p [-( l +  A)/](l + XY>-l t * - 1 (4 51)
for p < 1 and (1 + X)t > 0 We can now say that d l i / d t  is given by (4 49) where
0 < R i  < b 3e - xtp- 1 (4 52)
We have seen that h  is given by
I 2 = f  ( t ~  $)p_1 exp( \ s )b4se~ l esds  (4 53)
Jo
Making the same substitution u = t -  s we can say tha t h  =  h i  + I 22 where
h i  = b4e~le(1* ^ t f  tup~ l exp[( — 1 +  X)u]du,
Jo
I 22 = - b 4€^ l e^l+x^  f  up e x p [(- l +  X)u]du (4 54)
Jo
Making the change of variables v = (1 +  X)u as previously gives 
*■ -
646 1 ie<1+*>* [r(p) -  r(p , (1 +  A)i)] (4 55)( l +  A)»
Proceeding as before we can show that 
dln  fMe"1




0 < R i i  < 64e_ 1tp +  7-.— -■ r tp~ 1
Similarly we can show that
r -&<e 1 I n  = —---- . e
(1 +  A)
( i + A ) i  l { 1 + X ) t  y P e - v f o/(1 +  A)P+! JO








- ( 1  +  A)pi pe - ( 1+A>‘ +  p  /  vP -'e -v d v
Jo
- (1  +  A)pipe -(1+A)‘ +p[T(p)  -  r (p ,( l +  A)i)]{4 59)
(1+A)p+!
Proceeding as for d /21/eft, we c^n show that,
d/22 - b4pe~1
di (1 + A)p
r(p)e ( 1 + A ) i + R?2,
where
0 < #22 <
Similarly we can show that
h  = _ ^ 2 _  AtA»-2
(1 + A)
[r(p) -  r(p,M)]
and
where
^  =  J H - T ( p ) e M +  b~  ’ 
dt AP-3 W A-2 # 3,
0 < « 3  < A2M P_1 






^  = r(p)e(1+A)i
b3e- l b4e- l
■[(1 + X)t + 1] - b4pe
- l
( l  +  A)? -1 (1 +  A)piv~ ’ ' *J (1 +  A)p_
+ + (¿ae-1 + 62A2)ip“ 1 -  R,  (4 65)
where R  is derived from equations (4 52), (4 57), (4 61) and (4 64) and is given by 
R  = Ri  + R 21 -  R 22 4- R 3
< b4€ -f- b4e 1 b4e
-i,
&3e 1 + 1~T~.—TT 7T ;—7T +  A2b'
(1 + A) (1 +  A)
From equation (4 45) and equations (4 65) and (4 66) we have
c s*n(P*)







( l  +  A)p-> (1 +  A)pl'~ ' ' ~J (1 +  A)P_
+ b4e~l e~Xttp + (63e_1 +  62A2)e_A‘<p-1|  -  (4 67)
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where
a ^  sinipn)
0 < R  < C — y— e xt
7T
{b<e- ' t” + b3e~ '  +  +  A262 t J (4 68)
The values of all parameters and the incidence of HIV infection arising from equa­
tions (4 67) and (4 68) will be provided below in Tables 4 6 and 4 7
4.6 Quadratic Growth in A ID S Cases.
We now consider the case when a(t)  is given by
a{t) =  co +  cit  +  c2t2 (4 69)
We can easily show that h(t)  is as in (4 12) with F(s )  given by
F(s)  = C exp(A$)[c3s 2 -f c4s  -f c5J (4 70)
where c3 = A2c2)c4 = 4Ac2 +  A2ci and c5 =  2c2 +  2Aci -f A2c0 Making the change of 
variables s = t — u as previous gives
1 = exp(At) j  up~x exp(-Au)[c3u2 -  (c4 +  2c3t)u  -f f (t )]du,  (4 71)
Jo
where f ( t )  = c3t2 + c4i + c5 and I  is the integral of interest Using the same approach 
to evaluating the integral as in the previous case we can show that
h(t) = C ^ ^ - { [ c 3t’>+1 +{c4 + c3( l - p ) X - 1)tP + c5t’>-1 e \t
+ c3 _,2 , \_E±_ , 2c3(1 ~ P)1 C3p(p -  1) C4 ( l  ~ p )  C5 1 \AP-1 +  Lap-1 \P  J ‘ +  Ap+1 +  + AP- ! j
+ R,  (4 72)
where
0 < R  < C St~n~ —e~M { - c 3ip+1 -f (2c3(p -  1)A“ 1 -  c4)tp7T ^
+ (c3p(l -  p)A-2 +  c4(p -  1)A_1 -  c5)ip_1|  (4 73)
Parameter estimates and results for this choice of a(t)  are provided m Tables 4 8 
and 4 9
4.7 R esults
For each of the four cases the parameters for a( t ), the number of AIDS cases m year 
t is as given in chapter 3, where the number of AIDS cases diagnosed and reported 
m any one year from 1981 to 1989 were adjusted for reporting delays Throughout 
this chapter we have chosen to start with t — 1 corresponding to the first year (1981) 
that AIDS cases were reported The incubation period distribution, F( t )  which we 
work with is that observed by Anderson and Medley (1988) [4] F (2) is given by the 
Gamma distribution T(a,A) with a  = 2 7 and A = 0 19 This corresponds as we
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have seen to a mean incubation period of /x = 14 3 years and approximately 40% of 
all infected individuals progressing to AIDS within 10 years
For a(i) given by an exponential we have h(t)  given by (4 28) with parameters 
given in Table 4 1 below
Table 4 1




r(o 3) 2 9920
r (2 7) 1 5450
sm(p it) / k 0 2575
These parameters along with those given earlier in Chapter 3 for d0 and dt and 
equation (4 28) give rise to the estimates in Table (4 2) below for the incidence of 
HIV infection m Ireland from 1981 to 1992
Table 4 2
Expected Annual Incidence of HIV Infections, 
a(t)  exponential, equation (4 2)
Year W ithout W ith















When a(t) is given by the quadratic exponential (4 30) h(t)  is found from (4 37) 
and the NAG (1984) [38] bbrary program D01A JF Param eter values for a(t)  are as 
previous and the values of other parameters are given below in Table 4 3
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Table 4 3









In order to estimate h(t)  from (4 37) we required the values of d l / d t  where I ( t )  
was given in terms of the integral (4 40) We estimated d l / d t  using the forward- 
difference and central-difference formulae described above with step size of h = 0 001 
The values of I ( t ), I ( t  -f h) and I ( t  — h)  along with an estimate of the associated 
error obtained from (4 40) and the NAG (1984) [38] library program D01A JF are 
given in Tables 4 4a and 4 4b below
Table 4 4a 
Evaluating the Integral I ( t )  m (4 40)
t I ( t ) Error
1 5 27022 0 73x10^
2 11 8058 0 84xl0"7
3 25 8227 0 51xl0-6
4 57 9752 0 25xl0~5
5 135 5830 0 llx lO "4
6 332 2450 0 46xl0"4
7 855 4990 0 19xl0-3
8 2318 2300 0 78x l0 -3
9 6617 3900 0 32xl0-2
10 19911 9000 0 13xl0_1
11 63193 4000 0 60xl0_1
12 211620 0000 0 46xl0-1
Table 4 4b 
Evaluating the Integrals I ( t  -  / i ) , / ( i  + h) in (4 40)
t I{t  -  h) Error I ( t  +  h) Error
1 5 26565 0 76xl0-8 5 27479 0 74xl0-8
2 11 7966 0 85xl0-7 118150 0 85xl0’ 7
3 25 8022 0 52x10-« 25 8431 0 51xl0-6
4 57 9272 0 2 5 x l0 -5 58 0232 0 25xl0-5
5 135 4650 0 llx lO - 4 135 7010 011x 10- “
6 331 9390 0 45xl0~4 332 5510 0 46xl0-4
7 854 6690 0 19xl0"3 856 3310 0 19xl0-3
8 2315 8600 0 7 8x l0 -3 2320 6000 0 78x l0 -3
9 6610 2800 0 33xl0- 2 6624 5100 0 3 2 x l0 -2
10 19885 5000 014x10“ 1 19934 4000 013x10-1
11 63118 8000 0 61xl0-1 63268 2000 0 60xl0_1
12 211359 0000 0 47x10“ ' 211882 0000 0 46xl0-1
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Using the values for I ( t ) y I ( t - h )  and I ( t  + h) given above along with the central- 
difference and forward-difference formulae we arrive at the estimates for d l / d t  given 
in Table 4 4c below
Table 4 4c 















Error O(h) 0 ( h ¿)
Using the central-difference estimates for d l / d t  and equation (4 37) we arrive at 
the following estimates for h(t)
Table 4 5
Expected Annual Incidence of HIV Infections, 

















When a(t) is given by the linear logistic (4 43) we see that h(t)  is given by (4 67) 
with a(t)  as previous and the following parameter estimates,
Table 4 6




We are now in a position to provide estimates of h(t) ,  the annual incidence of 
HIV cases in Ireland from 1981 to 1992, given a linear logistic growth in the annual 
numbers of AIDS cases
Table 4 7
Expected Annual Incidence of HIV Infections, 
a(t) bnear logistic, equation (4 43)
















When a(t) is given by the quadratic (4 69), with parameters as given previously 
then parameters for h(t)  in (4 72) are as given below in Table 4 8
Table 4 8







Expected Annual Incidence of HIV Infections, 
a(t) quadratic, equation (4 69)
Year W ithout With
















We see from Tables 4 2, 4 5, and 4 9 that estimates of the total number HIV infec­
tious in Ireland from 1981 to 1989 inclusive ranges from 2751 to 10,826 This la a 
considerable narrowing of the range estimated in Chapter 3, where approximations 
to the fitted incubation distribution were used in all calculations From HIV test­
ing centres we know that there were approximately 1000 HIV individuals testing 
positive during the same time period However predictions diverge considerably for 
1990, 1991 and 1992 This is also the case with the predictions of Isham (1988) [25] 
based on approximations of the incubation period distribution We saw in Chapter 
3 tha t this divergence in predictions for later years is directly related to the nature 
of a(t) at these time points
If we look at each of the four cases individually, for predictions up to and includ­
ing 1989 we see th a t in the exponential case the is a large increase in the numbers 
becomming HIV positive in 1989 and the years thereafter This is a direct result 
of the choice of a(i) and is also evident in the quadratic exponential case In the 
latter we estimate 2536 cases m 1988 and 6297 cases in 1989 In the case of the 
hnear logistic we have negative numbers predicted from 1987 This is due to a(t) 
itself predicting low figures for these years With the quadratic case figures for the 
numbers of HIV positives increase evenly over the 9 years
Overall there is good improvement on the Chapter 3 estimates If we decide 
to look only at the totals to 1988, due to the large increases in the 1989 figures, 
we arrive at estimates of the numbers of HIV positives ranging from 2251 to 4529, 
representing the quadratic and quadratic exponential respectively This is a very 
encouraging improvement on all previous estimates and would lead one to believe 
that the methods discussed m this Chapter can be applied with increasing confidence 
as time progresses and we have more data with which to estimate a(t)
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C hapter 5
E stim ating D eaths and 
Prevalence.
5.1 Introduction
In this Chapter we attem pt to estimate the annual death rate from AIDS We are 
interested in the number of deaths arising from all associated AIDS illnesses and 
complications and not just those deaths where AIDS has been recorded on the 
death certificates In Ireland the National AIDS Co-ordinator regularly scans death 
certificates in order to identify AIDS related deaths (personal communication, Dr J 
Walsh, Department of Health) It is often the case that AIDS has not been recorded 
on the death certificate in order to respect the feelings of the deceased’s family All 
AIDS related deaths must be estimated in order to give a true picture of the extent 
of the disease
We also intend m this Chapter to estimate the prevalence of AIDS in Ireland 
by providing estimates of the numbers of AIDS cases alive each year This we shall 
accompbsh by looking at the numbers of new AIDS cases each year, as described 
earber in Chapter 3, and combine these with estimates of the annual death rate We 
shall provide predictions for the actual numbers of diagnosed cases as opposed to 
the reported numbers, as it is the actual number of diagnosed cases that the health 
services will have to provide for
5.2 M ethods
There are two ways in which estimates of the annual death rate can be derived One 
consists of the extrapolation from current figures on AIDS related deaths obtained 
by the Department of Health Using this approach one could in principle extrapolate 
the figures for the combined cases and for each risk group, so providing estimates of 
the annual death rate within each group Those most at risk could then be clearly 
identified and targeted by the health services
While this appears to be a reasonable approach in theory, this is not feasible 
within the Irish situation There are few deaths in the early eighties and cases 























1984 1 1 1
1985 1 1 1 1 1
1986 1 1 3 1
1987 6 7 1 2 1
1988 4 1 1 1 2
1989 7 1 1 1 4 1
Total 22 11 5 8 7 5
Also, if we plot the figures on deaths for the IVDU or homosexual/bisexual group 
we find no apparent pattern in the profiles For these reasons we seek a different 
approach to the estimation of annual death rates
Sir David Cox (1988) [16] provides predictions of deaths and prevalence based 
on estimates of the number of new AIDS cases per year and the distribution of 
survival times from the onset of AIDS to death We implement this approach here 
and again in Chapter 7, when we discuss our transmission models which predict 
from the number of susceptible through infectious to death This approach depends 
upon reliable estimates of survival rates of AIDS patients and the estimates of a(t) 
as derived in Chapter 3
5.3 Estim ating Survival Tim es
Data on the initial diagnosis of AIDS to date of death has not as yet been collated 
and analysed for Irish AIDS patients Data on survival times is not available m any 
single center Some patient information on these dates is available in the Dublin 
Gem to Urinary Chmc at St Jam es’ Hospital, Dubhn These files are in the process 
of computerisation Some information on rural cases is available in the Department 
of Health, where G P s report new diagnoses of AIDS Indeed it can be the case that 
diagnosis of AIDS and death are simultaneous The computerisation of records at 
St James’s Hospital will, when completed, enable one to analyse Irish survival rates 
However estimates of annual death rates depend upon estimates of survival rates, 
so for this reason we choose to work with estimates of survival rates as discussed 
by Reeves and Overton (1988) [43] and Cox (1988) [16] but we are aware of this 
implications this has on our final estimates of the Irish annual death rates
Reeves and Overton (1988) [43] performed a preliminary survival analysis of 725 
U K AIDS patients This was then compared with an analysis of trends by Marasca 
and McEnvoy (1987) [31] in 725 patients from the United Kingdom and 5833 patients 
from New York City The median survival time for selected subgroups was computed 
and found to be very similar to that of the New York group No major differences 




















prediction purposes it is the overall distribution of survival time (from diagnosis 
to death) that is of interest Reeves (1988) [44] updates original predictions on 
survival times with the analysis of 997 U K AIDS patients It was found that a two 
parameter exponential model given by £(<) = a exp (fit) fitted the data well, with 
0 08 equalling the probability of death and diagnosis being simultaneous, a median 
survival time of 9 2 months and a mean survival time of 1 14 years
Cox (1988) [16] when estimating the ratio of death and diagnosis rate, report
and diagnosis rate assumes a probability of 0 073 of diagnosis and death being si­
multaneous, a median survival time of 7 2 months and a mean survival time of 1 22 
years This distribution of survival times is plotted in Figure 5 1
Finally, the main point of interest from an Irish point of view of the Reeves 
and Overton (1988) [43] research is that the analysis of U K and New York City 
data gave similar results and that no major differences in median survival times 
were observed between risk groups We can therefore be more confident in using the 
predictions of survival times of others in order to estimate Irish annual death rates
9.4 E stim ating the N um ber o f D eaths
Assuming the distribution of survival times discussed in the previous section the 
r t^e of occurrence of deaths at time t is given by
d(t) =  70a(t) +  (1 -  70) j f  a(u)7 exp[~7( i  -  u)]<fa (5 1)
Intuitively this says that the rate of occurrence of deaths at time t depends upon
those cases where diagnosis of AIDS and death are simultaneous plus all cases that
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were diagnosed in the past and have survived up to the present time
If we assume that S ( t ) is as discussed above and a(t) is given by one of the four 
forms,
a(t)  = d0 exp(di t ) ,  (5 2)
a(t) = a0 exp(aii -  a2J2), (5 3)
^  =  (54>
a(t)  =  Co + c2i + c2i2, (5 5)
then d(t) can easily be derived analytically Here and throughout this chapter Greek 
and Roman letters denote constants which have been or will be estimated from the 
data If a(t) is given by equation (5 3) then d(t) may be derived numerically 
Case 0 if a(t) is given by equation (5 2) then,
d(t) = lodoexp(d\ t )  +  (1 -  70) f  ¿oexp(<fiu)7 ex p [-7 (tf -  u)]du (5 6)
Jo
When integrated this gives,
d(t) =  d0 e x p ( d i t ) - f 1^  7 -  j  T° do7 e x p (-7<) (5 7)
« 1 + 7  “ 1 + 7
Case 1 if a(t) is given by equation (5 3) then,
Jr tf a0 e x p (a iu - a 2u2)7 e x p [-7 ( i- t t) ]d ii (5 8) 
o
Taking terms containing t outside the integral gives,
d(i) = 70a0exp(a1i - a 2/2) + ( l - 7o)oo7 e x p ( -7 i) [  exp[(a! + i ) u - a 2u2]du (5 9)
Jo
The integral on the right hand side of equation (5 9) must be solved numerically for 
t, as we are looking for the integral of a quadratic exponential We are interested 
m values of t from 1 to 12 in order to estimate the number of deaths from 1981 
to 1992 To do this we employed the NAG (1984) [38] routine D01AJF This is a 
general purpose integrator which calculates an approximation to  the integral of a 
function F(x)  over a finite interval ( A yB)
Case 2 if a(/) is given by equation (5 4) then,
d(t) = 70a(t)  +  (1 -  70)7 exp(—7 )^ f  a(u) exp(*yu)du (5 10)
Jo
Consider first the integral on the right hand side of equation (5 10) above, which we 
denote by I  We have
1 = Jo exp(l -  u) exp(7M) + &2 GXP(~iu )du (5 11)
Splitting the above into the sum of three integrals gives,
/ =  f  ---- 7^  r exp(7u)du +  /  e _^P_(7^) + f 1 exip ( ju d^u (5 12)
Jo exp(l — u) Jo exp(l -  u) J0
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We can now say that I  = I x + i2 + £3 with the definitions of I \ , I 2, h  obvious 
Evaluating l\ we have,
integrating gives,
h  = f  60 exp[(7 +  1)« -  1 }du, 
Jo
h  = -^ rr  exp[(7 + l)i -  1]-------------17 + 1 7 ' 7 + 1
To compute / 2 we use integration by parts, starting from,




1(7+1) (7 + 1)2.
I 3 may be evaluated directly as,
¿>2
e x p [(7 +  l ) i  -  1] +
61 e- 1
( 7 + 1 ):
1 3  = — texP(7<) “ !]7






d(t)  = 70a(t) + (1 -  70)7 exp(—7*)
61
f>2 i .\ * (ba + b\t bi \  T exP(7 i ) + ( —
exp[(7 + l) i -  1] + bo - )  e_1 -  — 
1/ 7
(5 18)
(7 + l )2 7 + 
Case 3 if a(t)  is given by equation (5 5) then d(t)  is given by,
d(t)  = 70a(t)  + (1 -  70)7 exp(—7$) /  (c0 + cxu + c2u2) exp(7u) (5 19)
Jo
Again the integral on the right hand side of equation (5 19) can be calculated by 
splitting the integral into the sum of three integrals and integrating by parts We 
have,
I i =  cq exp(7u)du  (5 20)
Jo
which when integrated simply gives,
h  = — [expfrt) -  1]
7




which when integrated gives,
Finally / 3 is given by,
w Jo C2U2 exp(7u)du, (5.24)
which when integrated by parts twice gives,
h  =
C2t2 2C2t 2 c2 / \ 2C2exp(7 i) +
7  7  7'
Adding equations for / i , / 2 and / 3 and combining with equation (5.19) gives, 
d( t ) = 7Oa (0  + (1 - 7 o )
+ (1 -7 o )e x p ( -7 t )
(5.25)
9 , 2C2 v x Cl 2c2 vC2Ï +  (C l--------)i + (co-------- 1---- 2")





5.5 E stim ating T he Prevalence
The second objective of this chapter is to provide predictions of prevalence of AIDS 
in Ireland. The number of live cases will be the difference between the number of 
diagnosed cases and the number of deaths. We define p(t) to be the number of 
patients alive and diagnosed as having AIDS at time t. This is then given by
p(t)  =  /  [a(u) — d(u)]du. 
Jo
(5.27)
We consider the four cases where a(t) is given by equations (5.2) to (5.5) above. 
Case 0: if a(t)  is given by the simple exponential form (5.2) then,
7 o ^ i  +  7
7  +  d \
This is easily integrated to give
doexp(diu) +  —— ^ - d o ^  exp(- ' yu )du .  
7  +  «1
p(t) = do^— ^j- [exp(dxt) -  e x p (-7*)].
7 + «1
Case 1: when a(i)  is given by the quadratic exponential (5.3) we have,





but this integration cannot be performed analytically as we do not know the explicit 
form of d(u).  To solve we split (5.30) into the difference of two integrals given by
P(t) /  a(u)du — /  d(u)du.  Jo Jo
(5.31)
The first integral we can solve numerically by using a modified version of the NAG 
(1984) [38]library routine D01AJF. The second can be solved by implementing the 
NAG routine D01GAF which integrates a function which is specified numerically at 
four or more points over the whole of its range. This routine uses third order finite 
difference formula with error estimates, according to a method due to Gill and Miller 
(1972) [22]. We are interested in values of the integral when t takes on values from 
t = 1 to t = 12, corresponding to the years 1981 to 1992. This is straightforward as 
we have d(u) specified at at least four points when t > 4. To evaluate the integral
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between 0 and 1, 0 and 2 and 0 and 3, two further values of d(u) between 0 and 
3 had first to be computed When all required values of the integral were found, 
these were then subtracted from the corresponding values of a(u)du  to provide
the estimates of p(t)
Case 2 if a(t) is given by the bnear logistic type function in equation (5 4) then 
p(t)  is given by,
KO
(1 -  70)
= /  <*(«) -  7e
Jo
bi
-7U b2 -yt* bi
(7 +  I )2 7 +
J o . )  e-i -  
 i j
6o -f b\u 
7 +  1 ~ ( 7 + l )2
du (5 32)
The solution of the integral may be found by splitting the integral into a sum of sev­
eral smaller integrals The calculations are straightforward but tedious Integrating 
equation (5 32) above gives,
p(0
0  -  7o)
b0 + b i ( t -  1) — 7 bo bi
7 +  1 (7 +  I )2
+ -  b0 +  7 bo h
7 + 1 ( 7 + l ) 2_ ^7  + 1
c
’ bo bi e * +  62 1
11I __
7 + 1 (7 +  I )2 — e L 7 I----7J
(5 33)
The values of p(i) using the parameter estimates discussed earlier are given in Table 
5 2
Case 3 when a(£) is given by the quadratic in equation (5 5) we have,
p(<)
(1 -  7o)




1 -vu (  2 i / ^2  \ . Ci 2c2 \_e ( c2u* +  ( c i  )u +  C o  + T
7 V 7 7 7 /
du (5 34)
Again this integral is cumbersome but straightforward and may be solved by splitting 
into more managable parts The solution of p(t) is given by,
p(*) 
l - 7 o
5.6 R esu lts
ci 2 c 2
t + £ l j2 .
i--
--- 72 . 7.
t + -7* (5 35)
We use Table 3 2 as discussed in Chapter 3 for parameter estimates of a(i) Using 
Cox’s estimates on survival rates, and equation (5 7), equation (5 9) with routine 
D01AJF and equations (5 18) and (5 26) we can provide estimates for the rate of 
occurrence of AIDS related deaths at time t These are provided in Table 5 1 below
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Table 5 1 
Predictions of Number of Deaths
Year Case 0 Case 1 Case 2 Case 3 Known
1981 1 0 0 4 0
1982 1 1 1 2 2
1983 1 1 1 0 1
1984 2 2 2 0 3
1985 3 3 3 2 5
1986 6 5 5 6 6
1987 10 9 11 13 17
1988 18 18 21 23 9
1989 32 37 36 36 15
1990 56 82 40 52
1991 97 191 -44 70
1992 170 474 -534 92
The values oip ( t )  for equation (5 29), equation (5 31) with routine D01AJF and 
DOlGAf and equations (5 33) and (5 35) with parameter estimates discussed above 
can be found in Table 5 2 below
Table 5 2 
Predictions of Prevalence
Year Case 0 Case 1 Case 2 Case 3
1981 0 0 0 4
1982 1 1 1 3
1983 1 1 1 0
1984 2 2 2 0
1985 4 3 3 1
1986 6 6 6 6
1987 11 10 12 14
1988 20 19 22 25
1989 34 40 38 39
1990 60 87 43 57
1991 105 201 -46 78
1992 184 496 -562 102
5.7 D iscussion
The predictions of the number of deaths and prevalence of AIDS are based on the 
form of a(<) and the assumption that there is no major change in the distribution 
of times between diagnosis and death Obviously as there are improvements in 
the treatment of AIDS patients, the lengths of survival times will increase and the 
distribution will have to be reassessed
The total number of deaths to the end of 1989 given exponential growth in the 
number of new AIDS cases, is 71 This compares with 58 deaths known to the 
Department of Health at that time After 1990 the number of deaths increases 
more rapidly as would be expected from the exponential distribution The total 
number of deaths in the same period for a(t)  described by the quadratic exponential 
is 76 The figures for the number of deaths then increase very rapidly from 1990 
to  1992 and cannot be considered as predicative in any way If a(f) is given by the 
bn ear logistic form we arrive at a total of 80 deaths to the end of 1989 We then
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obtain negative results for 1991 and 1992 This is a direct consequence of a(t) itself 
becoming negative at this time for this form Finally, the quadratic form for a(t) 
gives a total of 86 deaths up to the end of 1989 This is a slightly higher estimate 
than the others due to the nature of the quadratic which predicts a larger number 
of deaths in the initial stages of the epidemic
Comparing the total number of deaths predicted from each of the d(t) with the 
known number of deaths in the same period we see that predictions differ with 
the known by factors ranging from 1 22 to 1 48 This we may use to obtain a more 
accurate picture of the actual numbers as opposed to the reported numbers of deaths 
in any period
All estimates on deaths are derived directly from the fits for a(i) which are in turn 
derived from those AIDS cases reported to the Department of Health As a result 
when we estimate p(t)  from both a(t) and d(t) we arrive at figures lower than those 
given by the Department of Health According to the department there was a total 
of 124 known cases of AIDS up to and including 1989 During the same period there 
were 58 known deaths This would lead us to beheve tha t there were 66 live cases of 
AIDS in Ireland at the end of 1989 However we bebeve, based on our calculations, 
that the figures for the numbers of deaths as pubbshed by the Department of Health 
are under-reported Our estimates of prevalence are then lower than those of the 
Department because we are working from the number of AIDS cases reported to the 
Department adjusted for reporting delays and subtracting the higher estimates for 
the numbers of deaths
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C hapter 6
H IV Transm ission Survey.
6.1 Introduction
The aim of this survey was to investigate the social, sexual and drug habits of those 
at risk from the Human Immunodeficiency Virus (HIV). It was our intention to 
look particularly at the rate of needle use in the drug abusing population and the 
rate of sexual partner change amongst all individuals at risk. In addition to this 
we aimed to estimate the rate of introduction to each of the at risk populations. 
This information is essential to the construction of any mathematical or statistical 
models for the transmission dynamics of the disease. It was our original intension 
to administer the survey at several centres, to encompass both HIV positive and 
negative individuals. Unfortunatly this was not possible at the time as a European 
study was already in progress at one of the planned administration centres. Given 
this obvious limitation, to our knowledge this is still the most comprehensive survey 
of this type, to date, in the Irish population at risk of HIV. Research on sexual 
behaviour has been carried out in America and Britain [29] but results from these 
countries cannot necessarily be applied to the Irish situation.
The participants in the survey were drawn from the Genito Urinary Clinic at 
St. James Hospital Dublin. All patients attending the clinic have been tested HIV 
positive. At the time of our initial pilot survey there was a total of approximately 300 
patients registered at the clinic, although not all of these were regular attenders. For 
the purposes of the pilot survey it was agreed with the clinic that twenty patients 
would be surveyed initially and we hoped to survey approximately two hundred 
patients in the final survey. Due to clinic difficulties and pressures of time a total 
of nineteen patients were questioned in the pilot and 187 patients questioned in the 
final survey. Details of the pilot survey report is provided in Appendix A. A copy 
of the final survey form is given in Appendix B.
The information collected in the final survey can be broken down into five cate­
gories. These were;
S ection  0 : In terv iew  D eta ils .
In this section the date and place of the interview was recorded. To check for inter­
viewer bias the interviewers’ initials were also noted.
S ection  1: P ersonal D eta ils .
This section included the patients initials, data of birth, sex, primary risk category, 
cohabitation status and information on where else the patient was under regular 
care. This final question was included to enable us to check for duplications, if the 
survey were to be administered at another centre at a later date.
S ection  2 : H IV  D etails .
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In this section the patient was asked how many times he/she had been tested for 
the HIV virus Each patient was then asked to give the dates of their last negative 
test and their first positive test We know from the Virus Reference Laboratory that 
many people have had more than one HIV test He/she was then asked if they had 
a regular partner and if so they were questioned on the HIV status of their partner 
and date of their partners first positive test He/she was also requested to state 
their CDC classifications and if they were classified as stage CDC 4 they were asked 
to state when they progressed to stage 4 
S ection  3a H e te ro sex u a l P a r tn e r  D e ta ils
Within this section patients were asked to describe their sexual activity pattern and 
if this pattern had changed since becoming HIV positive They were then asked to 
give their average number of partners per month and per year (as a check), the age 
at which they first became heterosexually active, if they used contraceptives and if 
so we asked what type of contraception was used We would consider the age at 
which a patient first became sexually active a key question This information may 
be used to estimate a transmission model parameter describing the introduction rate 
to the heterosexually active population 
S ection  3b H om osexual P a r tn e r  D eta ils
This section requested those who engaged in homosexual and bisexual activity to 
answer questions on their sexual activity similar to those asked of heterosexuals 
They were also asked to list their types of sexual activity 
S ection  4 D ru g  U se D e ta ils
Patients were asked if they had used intravenous drugs in the past If so they were 
then requested to give information on why and when they had stopped, estimates 
on the extent of their drug use, per day and per week, frequency of needle sharing 
and the lifetime of their needles Patients were also asked at what age they first 
used intravenous drugs This is also a key question and information from replies 
will be used to estimate the introduction rate to the male and female drug using 
populations Patients were then asked if their drug use pattern had changed since 
becoming HIV positive Female patients in this section were asked if they had given 
birth since becoming HIV positive and if so they were then asked to provide details 
on the HIV status of their children Finally patients were asked to bst any other 
relevant information
The data described above was collected by the medical staff at the chmc This 
included the consultant, the senior house officers and a research nurse The survey 
was administered by the staff while patients were attending the clinic for reasons 
associated with their HIV status The 187 patients invo lved  m the su rvey  were 
questioned on a first come first served basis
Finally the primary aim of the survey was two fold firstly to provide a compre­
hensive picture of the behaviour of those at risk from and capable of transm itting 
the HIV virus and secondly to generate the necessary da ta  for the estimation of the 
essential epidemiological parameters used in our transmission models of HIV within 
the Irish IVDU and homosexual populations, discussed in Chapter 7
6.2 M ethods
Descriptive statistics in the form of mean, mode, median, ranges and distribution of 
replies to questions were prepared Key questions, necessary for parameter estima­
tion, were identified and looked at in more detail In this section we shall also give 
a brief description of the steps followed to ensure accuracy
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All questionnaires were read and checked prior to data  entry For ease of reference 
each questionnaire was then assigned a case number and a batch number, completed 
questionnaires were returned in several batches on an ongoing basis Each question­
naire was also assigned a record number from 1 to 20, depending on the description 
of the patient and the number of variables to be recorded for that patient For ex­
ample record type one referred to male drug abusers and record type twenty referred 
to female bisexuals who used intravenous drugs and had no children Data was en­
tered in fixed format with each variable assigned a short variable name and fixed 
position Hardcopy records of the variable names and positions were kept, details of 
these along with a description of record types are available in Appendix D, (see file, 
Survey sps) Approximately one hundred variables were identified and from these, 
others, including the length of time the patient had been positive and the minimum 
length of the incubation period of those at CDC stage 4 were computed SPSSX 
the statistical package for the social sciences was used to analyse the data In order 
to  shorten subsequent command files all data  definitions and derived variables were 
stored in system files These could then be readily accessed
The statistical analysis of the survey was broken down into several sections which 
followed along the lines of the sections within the survey itself
6.3 R esu lts
In this section we shall briefly summarise our main findings In relation to key ques­
tions we shall first provide the overall findings and shall then spbt the results by 
risk group
Section  0 Interview  D etails
A total of 187 surveys were administered to the patients between November 1989 
and May 1991 To check for duplication of patients interviewed, the patients’ ini­
tials with the age they were at the time of the statistical analysis (May 1991) were 
cross tabulated From this we found that six patients were interviewed twice For 
each of these six, the second interview was deleted from the file and all subsequent 
analysis was carried out on the remaining 181 patients There was a total of ten 
interviewers identified, of these, one, a research nurse trained in survey and clinical 
trial adm inistration, carried out the majority, 75% or 135 of the interviews The 
senior consultant at the clinic administered the majority of the remaining 46 ques- 
tionaires
Section  1 Personal D etails
Initials, date of birth and sex of the patient were recorded Of the 181 patients sur­
veyed 119 or 65 7% were male and 62 or 34 3% were female, giving a male/female 
ratio of 1 9 /1 ,in agreement with the male/female ratio at the chmc Patients were 
classified into one of six risk groups 92 or 50 8% were identified as male IVDU, 
51 or 28 2% as female IVDU, 20 or 11 0% as male homosexual only, 3 or 1 7% as 
male bisexual only, 2 or 1 1% as male homosexual or bisexual and IVDU and 13 or 
7 2% as other risk The age of the 181 patients surveyed ranged from 18 years to 
40 years with 3 missing observations The distribution of ages for male and female 
IVDU’s and homosexuals is provided in the form of a stacked bar chart in Figure 6 1 
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Mean 28 85 26 63 30 32
Median 28 00 26 00 30 00
Std Dev 4 38 3 41 5 36
No of cases 92 51 19
As these three groups constitute the main risk groups, the reader interested in 
detailed age profiles for other risks is referred to Appendix D, file Surveyl out 
When questioned on their living arrangements 96 or 53 3% said they were bving 
alone or had living arrangements other than with a male or female partner When 
asked to specify most said they were living with their family, parents or brothers 
and sisters 41 or 22 8% said they were living with a male and 43 or 23 9% sajd they 
were bving with a female There was one missing observation in this question 
Most patients were in receipt of regular care elsewhere in addition to the care 
they received at St James’ hospital Only 5 of the 181 surveyed said they received 
no other regular care The replies to this question would be very important if the 
survey had been carried out at several centres as originally planned 
Section 2. HIV Details
Ifi this section patients were asked how many times they had been tested for the HIV 
virus and on which dates They were also asked to give their CDC classification and 
if at CDC stage 4 they were asked when they had progressed to this stage They
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were also asked about the HIV status of their regular partner It was hoped that 
some preliminary information on incubation periods and durations positive could be 
obtained from the patient replies to these questions
When asked how many times the patient had been tested for the HIV virus it 
was observed that repbes ranged from 0 to 20 times The mean number of times 
tested over all risk groups was 2, however 57% or 103 patients, were tested only 
once Two patients said they were never tested W ithin the male IVDU, female 
IVDU and homosexual groups most patients were tested only once for the virus 
The distribution of patients overall risk groups and within the male and female 
IVDU and homosexual groups over all CDC classifications is summarised in Table 
6 2 below Patients may be classified at one or more stages of the disease, AIDS 
Once a patient is classified as CDC stage 4, they are at the AIDS stage
Table 6 2
Distribution of patients o \er CDC classifications
CDC Over all Male Female Homo­
Classification Risks IVDU IVDU sexual
CDCl 1 1 0 0
CDC2 79 37 27 4
CDC3 54 24 18 8
CDC4a 1 0 1 0
CDC4b 0 0 0 0
CDC4cl 27 16 3 5
CDC4c2 10 7 1 2
CDC4d 1 1 0 0
CDC4e 3 3 0 0
Not Classified 1 0 1 0
Missing
Observations 4 3 0 1
Total 191 92 51 20
% at Stage 4 27 29 9 35
The length of time for which the patient had been positive at the time of interview 
was computed from the date of first positive test and date of interview When we 
looked at all 181 patient replies we found that data was missing for 55 patients This 
was due mainly to the fact that many people interviewed could not remember the 
month of their first positive test Looking at the remaining 126 patient rephes we 
found that the mean length of time patients had been positive was 2 08 years, with 
a median of 2 00 years, standard deviation of 1 83 years and a range of 0 to 6 years 
Most people, 35, had first tested HIV positive less than one year previous
There were 95 patients who had not yet reached CDC stage 4 and had dates of 
first positive HIV test The mean duration positive of these 95 patients was 1 99 
years, with a median of 2 00 years, range of 0 to 6 years and a standard deviation of 
1 83 years Again most of these 95 patients had first tested HIV positive less than 
one year previously There was a total of 29 patients at CDC stage 4 who had dates 
of first positive HIV test available The mean duration positive of these 29 patients 
was 2 48 years, with a median of 2 00 years, range of 0 to 6 years and a standard 
deviation of 1 83 years Most patients in this group had first tested HIV positive at 
least one year previous
A summary of incubation information for those who were at CDC stage 4 and 
for whom date of reaching this stage and date of first HIV positive test was available
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and is given m Table 6 3 below More details are provided in Appendix D in files, 
Survey21 out to Survey26 out
Table 6 3










Mean 1 65 1 63 - 186
Median 1 00 1 00 - 0 00
Mode 0 00 0 00 - 0 00
Std Dev 1 88 1 71 - 2 34
Range 0 - 5 0 -  5 4 0 - 5
No of cases 26 16 1 7
Of those patients who had a regular HIV positive partner we asked when their 
partner had first tested HIV positive Of the 181 patients questioned, 48 or 26 5% 
said that they had a regular partner who was HIV positive Of these 48, 21 knew 
the date of their partners first HIV positive test From these rephes we saw that 
the mean length positive of the regular partners was 2 38 years, with a median of 2 
years, standard deviation of 2 11 years and a range of 0 to 6 years positive Given 
the high percentage of non response to this question, these figures can at best be 
regarded as guidebnes
Section  3a H eterosexual Partner D etails
Within this section patients were asked various questions on the nature and extent 
of their heterosexual partner contacts As male and female IVDU’s make up 139 of 
the 155 patients to whom this section was relevant (the other 16 patients consisted 
of bisexuals, female IVDU’s with homosexual activity only and those male and 
female heterosexuals with other risks) we shall look at their replies in detail Those 
interested in the details of the other groups are referred to Appendix D
Of the 92 male (51 female) IVDU’s surveyed, 34 males and 21 females described 
their sexual activity as non existent, 16 males and 7 females as seldom or occasional, 
37 males and 16 females as frequent (at least once a week) and 5 males and 3 females 
as very frequent, (at least once a day) There was no reply given to this question by 
4 females surveyed
When asked if there had been any change in their sexual activity pattern since 
becoming HIV positive 39 males and 15 females said they had fewer partners, 48 
males and 31 females said there was no change and 3 males and 1 female said they 
had more partners There were 2 missing observations to this question amongst the 
males and 4 amongst the females
When asked for their current average number of partners per month 36 male 
IVDU’s and 22 females said they had no partners, 52 males and 25 females said one 
partner, 3 males and no females said 2 to 5 partners per month and 1 male and no 
females said they had six to ten partners per month No male or females said they 
had more than 10 partners per month There were no missing observations for the 
males and 4 missing for the females on this question
One of the key questions asked in this section was, the average number of partners 
per year The distribution of rephes given by the male and female IVDU’s to this 
question is provided in Figure 6 2 and summary statistics are in Table 6 4 Further 
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Table 6 4
Distribution of the number of partners per year
Male Female
_____________ IVDU IVDU
Mean 3 86 0 69
Median 100 100
Std Dev 21 85 0 47
No of Cases 91 47
Within the male IVDU’s, one patient said he had 208 partners per year This 
did not agree with this patients reply to the question on number of partners per 
month This patients reply has considerably distorted the summary statistics for 
this question and we shall take this into account in Chapter 7 when we are estimating 
the transmission model parameters If we ignore this obvious outber we see that the 
number of partners per year for the male IVDU’s ranges from none to 24
The age at which patients first became heterosexually active is also important 
for the transmission model parameters A summary of replies to this question for 
the male and female IVDU’s is given in Table 6 5 below
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Table 6 5





Mean 15 07 16 04
Median 15 00 16 00
Mode 15 00 16 00
Std Dev 2 10 2 40
Range 10 - 24 7 - 21
No of Cases 91 47
The female IVDU whose first heterosexual activity was at 7 years was a case of child 
sexual abuse The range for females if we ignore this one case was 11 to 21 years
When asked if patients or their partner used contraceptives 15 males and 24 
females said they never used any contraceptives 24 males and 4 females said some­
times and 49 males and 18 females said they always used some form of contraceptive 
When then questioned on the type of contraceptive used 69 males and 17 females 
said they used condoms or condoms plus another form of contraceptive 13 males 
and 22 females said they used no form of contraceptive Here we can see that there 
are small discrepancies in replies to this question 
Section  3b H om osexual P a r tn e r  D eta ils
Similar questions were asked of those who engaged in homosexual activity A total 
of 25 male patients said they engaged male homosexual activity Of these 3 were 
bisexual and 2 were either homosexual or bisexual plus IVDU Summary descriptive 
statistics were prepared for each of these three groups individually In this chapter 
we provide the replies of the purely male homosexual group only
Of the 20 replies received 8 described their sexual pattern as non existent, 6 as 
seldom or occasional, 5 as frequent (at least once a week) and 1 as very frequent 
(at least once a day) When asked if this pattern had changed since becoming HIV 
positive 14 said they had fewer partners and 5 said there was no change There 
was one missing observation on this question When asked to give their average 
number of partners per month, most, 12, said they had one partner per month 6 
said they had no partners and 1 said they had between 2 and 5 partners per month 
No patient had any more than 5 partners There was again 1 missing observation 
on this question
When asked to give the number of p a r tn e rs  p e r  y e a r rep lies ran g ed  from none to 
20 partners The replies to this question will play an important part in parameters 
describing sexual activity in transmission models The mean number of partners 
per year was 4 05, the mode was 1, median 2 and standard deviation of 5 16 All 20 
patients answered this question
When asked to hst their types of sexual activity 9 said they engaged in active 
sex, 11 in passive, 10 in oral and 11 in other types of sexual activity Only 6 patients 
said that they or their partner always used condoms, 5 said sometimes and 6 said 
they or their partner never used condoms There were 3 missing observations on 
this question
Patients were then asked at what age they first became homosexually active 
Again this will be a key question in any transmission model One patient did not 
reply to this question Of the 19 repbes received answers ranged from 12 to 24 years 
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replies were bimodal at 16 and 18 years and the standard deviation was 3 21 years 
Section 4* Drug Use Details
In this section patients were asked about the nature and extent of their drug use 
We shall look at the male and female IVDU replies separately
When asked if they used IV drugs in the past 90 of the 92 male and 49 of the 51 
female IVDU’s said they had used IV drugs in the past When then asked if they 
were using IV drugs now 25 males and 10 females said they were, the others had 
stopped for various reasons
One of the key questions in this section was the age at which the patient first 
used IV drugs The information from this question will be used to estimate intro­
duction rates to the male and female IVDU populations, for use in the transmission 
model Summary information for this question for males and females is provided in 
Figure 6 3 and Table 6 6
Table 6 6
Summary statistics for age of first IV drug use, in years
Male Female
_____________ IVDU IVDU
Mean 17 94 16 84
Median 18 00 16 00
Std Dev 3 69 3 01
No of Cases 92 51
When asked how often one would inject each day and each week replies were 
similar for both males and females A summary of replies given for daily IV injections
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\is provided below in Table 6 7
Table 6 7
Summary statistics for number of IV drug injections per day
Male Female 
IVDU IVDU 
2 80 2 28
3 00 2 00
3 00 3 00
2 53 1 50








asked if they shared needles with other IV drug users and 
would share with in one week Repbes varied considerably 
Table 6 8 below
Table 6 8





Mean 5 70 6 94
Median 2 00 3 00
Mode 100 0 00
Std Dev 11 93 9 44
Range 0 - 99 o t O
No of Cases 91 51
Patients were next 
how many people they 
and are summarised in
Although the mode in the female data was 0, (14 females said they shared with no 
one ), 8 females said they shared with 10 people per week There was one missing 
observation in the male IVDU data for this question
When asked about the bfe of needles 37 of the 91 males and 17 of the 49 females 
who replied to this question said that a needle would last less than one week 19 
males and 10 females said it would last 1 to 2 weeks, 17 males and 11 females said 2 
to 4 weeks and 18 males and 11 females said a needle would last more than 4 weeks 
Finally patients were asked if their drug use pattern had changed since becoming 
HIV positive 33 of 90 males and 22 of 50 females who repbed to this question 
saad that they used IV drugs less now 18 males and 10 females said they used IV 
drugs more often since becoming HIV positive Finally the remaining 39 males and 
18 females said that there was no change in their IV drug use since becoming HIV 
positive
Some preliminary information was collected in this section from those female pa­
tients who had given birth since becoming HIV positive Of the 62 females surveyed 
21 or 35% of the 60 who replied to this question said they had given birth since 
becoming HIV positive Of the 50 female IVDU’s who replied to  this question 16 
or 32% said they had given birth since becoming HIV positive When then asked 
the number of bve deliveries these 16 women had produced, 12 said they had 1 hve
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delivery, 2 said they had 2 live deliveries (not twins) and 1 women said she had 3 live 
deliveries since becoming HIV positive One women did not reply to this question 
A full discussion of the results and findings of this HIV survey are provided m 
Section 4 below, and the importance of certain key questions to parameter estimation 
is also discussed
6*4 D iscussion
The primary aim of this HIV transmission survey was to provide an insight into the 
drug use and sexual behaviour of the patients surveyed Questions in the survey were 
specifically designed to give the necessary information on essential mathematical 
model parameters This information we shall use to estimate key model parameters 
in Chapter 7 This transmission model will then be used to provide long term 
estimates of the prevalence of the HIV virus and eventual AIDS cases in Ireland 
The majority of questionnaires were administered by a research nurse in St 
Jam es’ Hospital Although it was originally planned to have 200 patients surveyed, 
due to time constraints only 187 were finally completed Obviously as time pro­
gressed those who attended the cbmc more often were already surveyed and it was 
difficult to survey those who attended less regularly We can see from the CDC 
distribution profiles in Table 6 2 that this did not imply that only those who were 
very ill were surveyed
The male female ratio of clinic attenders is known to be approximately 2/1 Our 
survey although carried out on a first come first served basis, also provided us with 
a male/female ratio of approximately 2/1 We also saw that the majority of patients 
surveyed were in the male IVDU group as expected from the known distribution of 
HIV cases in Ireland given m Chapter 1 These results lead us to be believe that 
those surveyed were a representative sample of those HIV positive in Ireland
The age profiles for those surveyed was as expected with the mean age in the 
homosexual group higher than that of the IVDU group Also we can see from Table 
6 1 that female drug users tend to be younger than male users The mean age of 
those using IV drugs was, however, higher than one might expect
As expected most patients received regular medical attention elsewhere in addi­
tion to St Jam es’ Hospital The information on where else patients received medical 
care would be of use if this HIV transmission survey were to be administered else­
where m the future Having successfully completed a pilot and main survey, we 
would be in a position to use our survey as a prototype for further investigations of 
this type in Ireland
As the mean number of times patients had been tested for the HIV virus was 
twice, data from viral reference laboratories on proportions testing HIV positive 
would have to be looked at in detail to ascertain if this had been taken into account 
It is interesting to note that the highest percentage of those at stage CDC4 
were within the homosexual group This confirms the belief that the homosexual 
group were the first group in Ireland to acquire the HIV virus Similarly, within 
the IVDU group more males than females surveyed were at stage CDC4 Replies 
to  the questions on how long since the patient first tested HIV positive and the 
known lengths of the incubation period for those at stage CDC4, provided in Table 
6 3, showed that patients incubation periods were very short, with the mode for 
incubation period and for length of time positive over all risks at less than one year 
This has serious imphcations for the health authorities in relation to planning and 
spread of the disease Patients are obviously not presenting for HIV tests until some
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time after they have actually become HIV positive This emphasises the importance 
of other methods such as the back projection method and the transmission model 
m ethod, wherby we can derive accurate estimates of the numbers HIV positive at 
any one time
Replies to questions within the IVDU group, on heterosexual activity were mod­
est, with the majority of both males and females describing their sexual activity as 
non existent Later questions however showed less modesty when the majority of 
males and females said they had on average one partner per month Earlier repbes 
may have been the result of the nature and position of the question withm the survey 
itself Repbes to questions on average number of partners per year and frequency 
of sexual contact also seemed more realistic, with the exception of one male reply 
Repbes to the age of first heterosexual activity showed that males became sexually 
active at an earber age than women
From the point of view of transmission of the disease it was distressing to note 
tha t 13 males and 22 females said they used no form of contraceptive This may 
be due to lack of care with regard to the transmission of the virus or it is also 
possible tha t some of these replies came from those whose regular partner is also 
HIV positive
Questions on homosexual activity appear to be truthfully answered While this 
is generally uncommon in surveys of this nature [29], (in Ireland homosexuality is 
illegal), patients’ past medical histories and risk group information is already known 
to the d im e’s medical staff Also, as surveys were administered in a genito urinary 
clinic both staff and patients are familiar with asking and replying to questions of a 
sensitive nature
Replies to the questions on drug use were also comprehensive A11 patients 
surveyed answered the key questions on the age of first drug use and number of 
injections per day The majority of IVDU’s injected 3 times a day and the mean 
number of people shared with in one week was approximately 6 These repbes 
have serious consequences for the transmission of the HIV virus between drug users 
Finally we see from the survey repbes tha t approximately one third of all women 
surveyed had given birth since becoming HIV positive This confirms Ireland as one 
of the countries where mother to infant transmission cannot be ignored
We believe that this survey, as a prototype, was very successful It has demon­
strated  tha t patients attending clinics are wilbng to answer questions of a personal 
and delicate nature We believe that the administration of the survey by trained 
medical staff contributed to this Some short-commings must however be mentioned 
All patients surveyed were HIV positive, we were unable to administer the survey 
amongst non HIV positive individuals at risk of infection Also, we were unable to 
contact the haemophiliac and heterosexual groups The survey has, however, high­
lighted those areas where urgent health education is required, the results themselves, 
in relation to presenting for HIV tests at an early stage, condom use, births to HIV 
positive mothers and needle sharing provide a case for this Finally it provides us 
with the necessary and detailed sensitive data  required for parameter estimation for 
use in our transmission models
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C hapter 7
D eterm in istic  M odels for H IV  
and its Progression to  A ID S.
4 All epidemiology, concerned as it is with the variation of disease from 
time to time or from place to place, must be considered mathematically, 
however many variables are implicated, if it is to be considered scientif­
ically at all
And the mathematical method of treatment is really nothing but the ap- 
pbcation of careful reasoning to the problem at issue ’ Sir Ronald Ross,
1911 [44]
7.1 Introduction
Sir Ronald Ross was awarded the Nobel Prize for his contributions to the detection 
of the transmission modes of malaria He recognised and published the importance 
of the mathematical model in the study and control of infectious diseases It is with 
the sentiments expressed by Ross above that we boldly proceed in this chapter 
Research on mathematical models of the HIV virus and its progression to AIDS 
has to date concentrated on the homosexual community In many parts of western 
Europe and America the majority of cases of the virus were identified within this 
group To-day, however, researchers are returning to their models and using the 
insights gained from them to model spread of the disease within the heterosexual 
population From the beginning of the AIDS epidemic in Ireland it was observed that 
we were unlike the rest of western Europe, and would have to proceed immediately to 
the difficult problem of modelbng the spread of the HIV virus within the intravenous 
drug users, who comprised the main vector of spread in the Irish population The 
research presented in this chapter on parameter estimation and model building is 
the first and only work of i t ’s kind in Ireland The aim of this research was to 
predict levels of HIV infection within both the Irish intravenous drug using and 
homosexual populations This chapter represents a significant first step towards 
these objectives We would envisage the extension of this work to encompass more 
accurate parameter and model predictions along with a qualitative study of the 
models employed This can only only be achieved by the continuation of the HIV 
survey discussed in Chapter 6
Encouraged by the advice of Ross, ‘however many variables are implicated method 









Primary Route Secondary Route
Figure 7 1 Transmission Routes of the HIV virus within the IVDU groups
in this chapter to describe and formulate simple mathematical models for the spread 
of the HIV vims in the Irish IVDU and homosexual populations, to estimate key 
model parameters from the HIV survey described in Chapter 6 and finally to provide 
predictions and recommendations based on the results of the models
7.2 IV D U  Transmission M odel w ith  Recruitm ent.
The routes of transmission of the HIV virus from and to the male and female IVDU 
group can be seen in Figure 7 1 above We have both primary and secondary trans 
mission routes, with primary routes representing the main routes of transmission
For practical reasons of parameter estimation and simpbcity we restrict our 
model to the primary routes of transmission and to within the male and female 
drug using populations We assume that the population mixes homogeneously, that 
all infectious individuals eventually develop AIDS and we make the further assump 
tion that those in the AIDS class do not contribute to the spread of the disease The 
assumption that all HIV positive individuals progress to the disease is reasonable 
Recent evidence suggests [16] that the proportion of people infected with HIV who
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eventually develop AIDS is higher than originally thought and may be as high as 
80% or even greater as the the duration of the incubation period is seen to increase 
We split the total population of drug users at time t into three exclusive com­
partm ents of susceptibles, infectious and AIDS, denoted by X ( t ), Y ( t )  and 4 (/)  
respectively We denote the different sexes within the population by the subscripts 
mu and fu, for male and females Hence the population of male drug users at time 
t is denoted by Pmu(t) and the population of female drug users at time t is denoted,
P/«(0
Suppose now we have a freely mixing community of Pmtt male drug users and 
P j u female drug users Let the rate of sexual contact of females with males be c /u 
per unit time Then in unit time X j u susceptible females contact c j uX j u males, 
of whom (c fuX f u)(Ymu/ P mu) are infected Let the probability of infection passing 
from an infected male to a susceptible female be 0i  in a single contact, (1 e /?i is 
the male to female transmission probability) then the rate at which new female drug 
user infections occur as a result of sexual contact with a male drug user, is given by
y
n  \ r  1  mu CfuP\Xf\
p,mu
Similarly, the rate at which new male drug user infections occur as a result of sexual 
contact with a female drug user is given by
cmuP'iXmJ ~ L,
where P2 is the probability of female to male transmission and cmu is the rate of 
sexual contact for males per unit time
The rate at which new male and female drug user infections occur will also 
depend upon the extent of needle sharing within the drug using population Let the 
rate of needle sharing per unit time for females with other males and females be n j u 
per unit time Then in unit time X f u susceptible females contact n j uX f u males and 
females of whom n j uX f u(Ymu + Y f u) /(Pmu +  P ju) are infected Let the probabibty 
of infection passing from an infected drug user to a susceptible drug user via needle 
sharing be /?3 in a single contact Then the rate at which new female drug user 
infections occur due to needle sharing is given by,
KfuPzXfu Ymu 4" Y j u
Pmu + Pfu
The rate at which new male infections occur due to needle sharing is given by,
Yjriu "f" YSu
Pmu + Pju
Where n mu is the rate of needle sharing per unit time for male drug users
The number of susceptible male and female drug users, X mu and X j n respec­
tively, will increase due to recruitment to the drug using population and will decrease 
due to sexual contact and needle sharing with infectious female and male drug users 
The number of susceptibles will also decrease due to normal migration rates out of 
the drug using population The rate of change m the numbers infectious will de­
pend on recruitment from the susceptible classes and loss to the AIDS class through 
incubation of the disease and normal migration Finally the rate of change in the 
AIDS classes will depend on those in the infectious class who have incubated the
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disease and loss due to death from AIDS and normal migration out of the drug using 
population
We can now formulate a differential equation transmission model to describe the 
rate of change in the number of susceptible, infectious and AIDS patients in the 
male and female intravenous drug using populations We have,
d X mu(t)
dt













Ymu( t ) +  Yfu (t)
Pmu(t) + Pju(t)  
(a  +  {i)Ymu(t),








d A fu (t)
dt
Where
Ymu(t) + Yfu (t) 
Pmu(t) +  P /u (0  
(a  + f i )Y fu(t),
+  C j u h X /u(t)
Ymu(t)
Pmu(t)
aYmu(t) -  (6 + fi)A mu ( 0 .
“ */«(<) -  (tf + n)Aju(t)
Pmu{t) = X mu(t) + Ymu(t) + A m u  (0,






-^mu(O), ^yu(0), Vrnu(O) and y /u(0) are known constants and A mu(0) = A / u(0) = 0 
Amtl and A /u are the recruitment rates to the male and female IVDU populations 
respectively, 1 /a  is the mean incubation period, 1/6 is the AIDS related death rate 
and l / f i  is the mean migration period This model is based on the one sex model 
of Anderson et al (1986) [5] Included within the (1986) model are two additional 
classes One the class of infectious individuals who do not go on to develop AIDS 
and two, a class of post infectious seropositives Anderson et al include recruitment, 
loss due to sexual activity with an infectious person and migration in their model 
Here we also incorporate loss due to needle sharing into the model In [5] the initial 
number of infectious people is assumed to be one We use the model in equations 
(7 1) to (7 8) to describe the spread of HIV in the drug using population given a 
stated, known number of HIV positive people at a certain point in time
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7.3 H om osexual M odel w ith  R ecruitm ent.
We now proceed with a simple compartment model which describes the transmis­
sion dynamics of the HIV virus within the male homosexual community We do
not consider the contribution of bisexuals to the numbers of susceptible, infectious 
and AIDS This model is also given in terms of a set of differential equations which 
describe the rate of change in the susceptible, infectious and AIDS classes This 
model was first proposed by Anderson et al in 1986, [5] and was later developed by 
Blythe and Anderson in 1988 [9] We have,
= A hm -  ChmfaXhmit) ~ PhmXhm(t)i (7 9) 
=  e*m/34*Am( 0  -  ( a  +  M*m)yfcm(0, (7 10)
= a rfcm(0 -  (<5 + WkmMkmCO (7 11)
Phmit) = x hm(t) + Yhm(t) + Ahm(t) (7 12)
The initial values of are known constants and 4 /^ (0 )  = 0 In this
model X, y, j4, P  represent the numbers of susceptible, infectious, AIDS and the total 
population as previously and the subscripts hm denote the homosexual population 
The parameter /?4 represents the probability of transmission of the disease in a single 
homosexual contact and all other parameters are as previously defined We are also 
assuming homogeneous mixing
7.4 Transm ission M odels, Param eter Estim ates.
All parameters were estimated from the HIV survey discussed m Chapter 6 and from 
data on HIV testing supplied by the National Virus Reference Laboratory at the 
Department of Medical Microbiology, University College Dublin This is the first 
attem pt at parameter estimation in Ireland To our knowledge very bttle survey 
work has been pubbshed on the difficult and sensitive information regarding needle 
sharing, frequency of needle use and needle life 
In tro d u c tio n  R a te s
The objective of this section was to provide actual realistic figures on the numbers 
of males and females taking up intravenous drugs for the first time each year in 
Ireland This data would then be incorporated into the model to provide details of 
how the total size of the intravenous drug using population changes from year to 
year In order to estimate the introduction rates to the male and female sexually 
active IVDU populations we began by considering the year of first drug use and 
year of first sexual activity of the 92 males and 51 females surveyed Details of the 
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As the risk o f in fection from  the use o f IV  drugs is known to be far greater than 
tha t from  heterosexual sexual contact we decided to  estim ate the in troduction  rate 
from  year o f f irs t IV  drug use only. From th is we saw th a t 75% o f males and 64% 
o f the females surveyed firs t took drugs before 1980. None o f the males and only 2 
o f the females took the ir firs t IV  drugs after 1986. We had hoped to  combine the 
percentage ta k in g  the ir firs t IV  drug each year w ith  the known number o f IV  drug 
users, from  the N ationa l V irus Reference Laborato ry, to  derive a m inim um  number 
o f people tak ing  IV  drugs each year. This was not possible as none of those IV  drug 
users surveyed took the ir firs t IV  drug in recent years. We saw from the survey 
however, th a t the male drug users took the ir firs t IV  drug over a period of 22 years 
and from  th is we could say th a t on average 4.55% took th e ir firs t IV  drug each year. 
Female drug users surveyed took the ir firs t IV  drug over a period of 17 years and 
from  th is  we could say tha t on average 5.88% took th e ir firs t IV  drug each year. We 
then combined th is  in form ation w ith  in fo rm ation  on the m in im um  number of drug 
users users known from the virus labora tory to derive a m inim um  estimate o f the 
numbers ta k in g  IV  drugs for the firs t tim e each year. Results for th is parameter are 
provided in  Table 7.1 below.
A  s im ila r approach was used to estimate the in tro d u c tio n  rate to the male ho­
mosexual popu la tion  each year. We see from  Figure 7.4 th a t the homosexuals ques­




f X  I YEAR HOMOSEXUAL
tha t on average 4.17% become active each year. Th is figure can then be combined 
w ith  da ta  on the to ta l numbers o f homosexuals from the virus  labora to ry  to give a 
m in im um  estim ate o f the numbers becoming homosexually active each year. Results 













Group . Param eter Value
Male IV D U Amu 119
Female IV D U A /u 64
Homosexual A /vrn 66
M igration R ate.
The objective in th is  section was to  estimate the actual numbers th a t stop tak ing 
intravenous drugs each year or tha t cease to  be homosexually active. To estim ate 
m igra tion  rates ou t o f the male and female drug using populations we com puted the 
length o f tim e for which those surveyed had used IV  drugs for. T h is  was derived 
from  questions in the H IV  transmission survey on date o f firs t IV  drug use and date 
at which the pa tien t stopped using IV  drugs. Not all o f those whom we surveyed 
had given up IV  drugs at the tim e o f in terview . For these we computed a m in im um  
period o f IV  drug use from  date o f firs t use to  date of in terview . Details are provided 
in  Figure 7.5.
FIGURE 7.5
DURATION OF IV DRUG USE
NUMBER OF YEARS 
1 \  I MALE ivdu \ / /  A fem a le  ivdu
The mean dura tion  o f IV  drug use was computed for males and females and the 
reciprocal o f th is was used as an estimate o f the m igration rate out o f the male and 
female IV D U  populations. Results are provided in Table 7.2.
To derive the m igra tion  rate ou t o f the male homosexual popu la tion  we again 
looked at the length o f tim e for which those surveyed had been homosexual. The 
results are given in  Figure 7.6.
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FIGURE 7.6
NUMBER OF YEARS HOMOSEXUAL
  NUMBER OF YEARS
[ \ ~ 1  NUM8ER OF YEARS
We found that all surveyed were still homosexually active and had been so for a 
mean of 13.78 years. We decided to use the Blythe and Anderson (1988) [9] approach 
and estimate of 30 years for the mean duration of homosexual activity as the mean 




Male IVDU /¿mu 0.107
Female IVDU /*/u 0.125
Homosexual Uhm 0.033
Sexual A ctivity .
In our transmission model we describe the parameters cmM,cyu and Chm as the mean 
number of partners per unit time. It is suggested elsewhere [33] that a better estimate 
of this parameter is given by the mean number of partners per unit time plus the 
variance to mean ratio. From questions in our survey on the average number of 
partners per year we could easily compute this param eter for both the male and 
female IVDU and homosexual populations. Details of replies to this question were 
given in Chapter 6. Results for the parameter are provided in Table 7.3, where the 





















7.440 6.400 to 10.770
1.007 0.958 to 1.166
10.610 10.570 to 17.840
N eedle Sharing.
The nature and extent of needle sharing is a key factor of spread of HIV amongst the 
intravenous drug using group. Loss from the susceptible to the infectious population 
will depend primarily on the parameter. Very little is know about the needle sharing 
habits of drug users. In our survey we were very fortunate to obtain such detailed 
replies by so many drug users.
We saw in the model (7.1) to (7.8) that the rate at which new HIV infections 
occur amongst male and female IVDU’s depends upon the the extent of needle 
sharing within the population. In our survey we asked how many people one would 
shared needles with in one week, we also asked how long a needle would last. It was 
thought unrealistic to ask how many people one would share with in one year as 
patients could not be expected to remember and give accurate replies. We decided 
to use results from the question on number of people shared with in one week as a 
minimum estimate for the needle sharing parameter, and details of the replies are 
given in Figure 7.7. We found that one male IV drug user said he shared with 99 
people in one week. Replies this patient had given to other questions on needle use, 
such as frequency of IV injections per day , were not consistent with this answer and 
it was decided to treat this case as an obvious outlier. Results on the mean number 
of people shared needles with for females, and males without this outlier, along with 
the corresponding 95% confidence intervals computed as previously are provided in 
Table 7.4. FIGURE 7.7
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Number Shared Needles with per Week
Group Parameter Value 95% C I
Male IVDU T^TiU 4 667 3 253 to 6 081
Female IVDU 6 941 4 298 to 9 584
Other Parameters
The mean duration of survival time from the onset of AIDS to death, 1/6, was 
assumed to be 1 year in accordance with known estimates [9] From our survey we 
examined all patients who were at CDC stage 4 (AIDS) and found the mean length 
of time from date of reaching stage 4 to date of interview to be 10 5 months This 
can be seen in Figure 7 8
The mean incubation period, 1/a» was taken as 8 years from published estimates
[5] The probability of transmission in a single sexual contact, f t ,  02 and f t  from 
an infectious male to a susceptible female, from an infectious female to a susceptible 
male and from an infectious homosexual to a susceptible homosexual respectively 
were also taken from published estimates [18] As we know of no published estimates 
of the probability of transmission of the virus in a single needle sharing act we used 
the estimate of /?i as a lower bound It is known that the probabibty of transmission 
during needle sharing is at least as great as that due to sexual contact Parameter 
values used are given in Table 7 5
FIGURE 7 8
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7.5 Transm ission M odel R esults, M inim um  Values.
To provide estimates of the level of HIV infection m the Irish IVDU and homosex­
ual populations we solved the models described in equations (71) to (78) and 
equations (7 9) to (7 12) using the NAG [38] bbrary routine D02EBF This rou­
tine integrates a stiff system of first-order differential equations over a range with 
suitable initial conditions, using a variable-order, variable step Gear method, and 
returns the solution at points specified by the user The driver program for this 
routine is supplied in Appendix C HIV testing first started in Ireland in 1985 We 
choose then, to model the spread of the disease over a range of 15 years, from given 
initial values in 1985 to predicted values in the year 2000 We assume that there are 
no great changes in the habits of the population during that time and that no HIV 
vaccine will be introduced during that time Numbers of susceptible, infectious and 
total tested at the end of 1985 for the IVDU and homosexual groups were obtained 
from the virus laboratory and used as initial values This was the only accurate data 
available and used as initial values will provide us with a minimum estimate of the 
initial prevalence in each compartment of the transmission models D ata from the 
virus laboratory combined figures for male homosexuals and bisexuals We used the 
ratio of male homosexuals to bisexuals found in our survey to split the combined 
number provided Parameters used are given m Tables 7 1 to 7 5 above and initial 
values are provided in Table 7 6
Table 7 6 
Transmission Model Initial Values
Group Susceptible Infectious AIDS Population
Male IVDU 358 128 0 486
Female IVDU 97 48 0 145
Homosexual 246 23 0 269
Predictions for the numbers susceptible, X ( t ), infectious, Y ( t ), and with AIDS, A (t) ,  
at time t, from the transmission models are given in Tables 7 7 and 7 8 These results 
are based, as we have stated earlier, on the assumption that there are no changes in 
behaviour or introduction of Government intervention policies during the 15 years
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Table 7 7 
IVDU Transmission Model Results
Year X m(t) X j ( t ) Yn (t) *7(0 A m(t) A f (t) ^m (0 Pj(t)
1985 358 97 128 48 0 0 486 145
1986 244 89 281 91 17 5 542 185
1987 154 69 391 137 32 11 576 216
1988 110 56 442 167 43 15 595 239
1989 95 51 461 186 48 18 604 255
1990 89 49 467 198 51 20 608 267
1991 87 48 470 206 52 22 610 276
1992 87 48 471 212 53 23 611 282
1993 86 48 472 216 53 24 611 288
1994 86 48 472 220 53 24 612 292
1995 86 48 473 223 53 24 612 295
1996 86 48 473 225 53 25 612 297
1997 86 48 473 226 53 25 612 299
1998 86 48 473 228 53 25 612 300
1999 86 48 473 229 53 25 612 302
2000 86 48 473 230 53 25 612 302
We can see from Table 7 7 that the susceptible population diminishes very quickly 
and remains at a constant level after 1993 The total population of male and female 
drug users continues to  rise slowly The values predicted in each of the compartments 
do not represent the true size of the IVDU population a t that time but rather the 
size of the population based on the initial minimum numbers fed to the model 
Given this restriction the model predicts a rapid increase in the numbers of infectious 
IVDU males, Ymtt(i)> between 1985 and 1989 and in the numbers of infectious IVDU 
females, Y fu(t), between 1985 and 1990 W ith the total number of IVDU’s HIV 
infectious rising from 176 in 1985 to 665 in 1990 After these increases the numbers 
infectious remain stable with a total of 703 IVDU males and females infected by the 
year 2000 The growth in AIDS cases is more rapid amongst male drug users with 
no cases m 1985 and 17 cases in 1986 There are only 5 cases of AIDS amongst 
female drug users in 1986 Figures continue to rise very slowly giving a total of 78 
cases m the year 2000
It is interesting to compare the results of the IVDU transmission model above 
with the results of the improved back projection method discussed in Chapter 4 The 
model above predicts a minimum of 647 HIV positive male and female drug users in 
1989 This does not include those with AIDS The virus reference laboratory knew 
of 520 HIV positive drug users in 1989 These 520 represented 57 15% of all known 
cases If we assume that the transmission model prediction of 647 cases m 1989 
represents 57 15% of all cases at that time we arrive at an estimate of 1,132 infectious 
people in Ireland m 1989 This is a lower figure than tha t estimated in Chapter 4, 
where, by improving upon the back projection method we predicted between 1,978 
to  10,610 infectious people, by summing the estimated annual incidences from 1985 
to  1989, (see Tables 4 2, 4 5 and 4 9)
Results of the transmission model in equations (7 9) to (7 12) describing the 
spread of HIV infection in the male homosexual community are given in Table 7 8
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Table 7 8
Homosexual Transmission Model Results
Year X hm(t) Yh n (t) Ahm(t) Phmif)
1985 246 23 0 269
1986 271 50 3 324
1987 269 98 7 373
1988 238 166 13 417
1989 191 239 21 451
1990 148 300 29 477
1991 117 341 36 494
1992 99 366 41 506
1993 89 380 44 513
1994 84 387 46 517
1995 81 392 47 520
1996 80 394 47 522
1997 79 396 48 523
1998 79 397 48 524
1999 79 398 48 525
2000 79 398 48 525
We see from Table 7 8 that the population of male homosexuals is increasing due 
to the fact that the recruitment rate is greater than the migration rate Again we 
do not presume th a t this represents the actual size of the homosexual population in 
Ireland but rather a minimum estimate based on the initial values The number of 
infectious homosexuals rises from 23 in 1985 to 50 in 1986, giving a doubhng time 
of approximately one year This pattern continues until 1988 after which the rate 
of increase in the numbers infectious slows down Both the numbers infectious and 
the number of AIDS cases stabilise at approximately 390 and 47 respectively after 
1995
Results presented in this section represent predictions on the minimum numbers 
HIV positive and with AIDS from 1985 in the IVDU and homosexual populations 
It will be interesting to see how the predictions, based on calculated initial values 
and spread from 1980, of the next section compare with the 1981 to 1989 predictions 
of the improved back projection method
7.6 IV D U  Transm ission M odel R esults Using Calcu­
lated  In itial Values.
In the previous section results presented were based on the minimum numbers of IV 
drug users known to  the virus reference laboratory In this section we shall assume a 
population of 5000 male and 2500 female susceptible IV drug users These numbers 
are based on a crude estimation of the size of the IVDU population using the direct 
approach as discussed by Hillier (1988) [16] We introduce one male infectious into 
this population at time t = 0 equivalent to 1980, and model the transmission of the 
infection through the population given certain assumptions We continue to assume 
the same percentages take drugs for the first time each year as we found in our HIV 
transmission survey This gives an introduction rate of approximately 228 male 
IVDU’s and 147 female IVDU’s each year All other parameters are as given earlier 
and we assume th a t initially there are no AIDS cases in the population We then 
model the spread of the infection over a period of twenty years from 1980 to 2000
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given no changes in behaviour or introduction of Government intervention policies 
The total number of HIV infectious drug users and AIDS cases expressed as a propor 
tion of the total population size are plotted in Figure 7 9 We have proportion HIV 
infectious equals y(i) where y(t) = (ymu(0  + Yfu{t)]/[Pmu(t) +  ^ /u (0 ] an(  ^ P1*0- 
portion of AIDS cases equals a(t) where a(i) = [/tmu(0  +  A ju(t)]/[Pmu(0  + /%(*)] 
We can see from Figure 7 9 that initially there is a rapid increase in the proportion 
HIV infectious This proportion infectious peaks 9 years after the introduction of 
the infection and then decreases sbghtly over the next 11 years The first AIDS cases 
appear 4 years after the introduction of the infection and the proportion with AIDS 
peaks after 11 years If we assume that the infection was introduced by a single HIV 
positive male drug user in 1980 then the model predicts a total of 2663 infectious 
(but not AIDS) and 327 AIDS cases in 1991 These decrease to 1584 infectious and 
183 AIDS cases by the year 2000
FIGURE 7 9
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We arrive at some encouraging results if we now compare the IVDU transmission 
model with calculated initial values, predictions for infections amongst IV drug users 
m 1989 with those figures predicted by the improved back projection method of 
Chapter 4 The improved back projection method predicts a range of 2,358 to 10,826 
infectious people in Ireland between 1981 and 1989 According to the transmission 
model, there were a total of 3,316 infectious IV drug users, Ymu(t) + V/U(f)i in 
Ireland m 1989 We have seen that IV drug users account for 57 15% of all known 
HIV positive people. Given this percentage and the transmission model predictions, 
we estimate a total of 5,802 infectious people m Ireland in 1989 This number, 
derived from the transmission model predictions is in the middle of the 2,358 to
10,826 range predicted by the improved back projection method
Looking closer at the individual predictions of the improved back projection 
method we see that given exponential growth in AIDS cases this method predicts a 
total of 4,824 infectious people between 1981 and 1989, (Table 4 2) This prediction 
is very similar to the 5,875 cases predicted by the transmission model above As 
a result of the similarities in the results of the two methods we can approach the 
next section, assessing the effects of possible Government intervention policies, with 
increased confidence
7.7 IV D U  Transmission M odel R esu lts given Interven­
tion Policies.
We now model the spread of the infection given the calculated initial conditions for 
1980 discussed above and we set the parameters cmu and c /u equal to zero from 1991 
This is equivalent to assuming that all drug users do not have unprotected sexual 
contacts from this time, this may be the result of a Government safe sex campaign 
Given these conditions the model predicts a total of 1496 male and female IVDU’s 
HIV infectious and 172 AIDS cases by the year 2000
If a large scale needle exchange program was introduced in 1991 instead , this 
would be equivalent to setting nmu = n /u = 0 from 1991 Under these circumstances 
the model predicts 1043 HIV infectious and 123 AIDS cases by the year 2000 This 
is a considerable decrease from the 1584 infectious and 183 AIDS cases predicted 
by the model given no intervention policies The proportions HIV infectious and 
with AIDS given these three situations are plotted in Figure 7 10 and Figure 7 11 
respectively
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7.8 Discussion.
The objective of this chapter was to provide estimates of the size of the HIV positive 
population in Irish IV drug users and homosexuals Our aim was to achieve this by 
the implementation of transmission models describing the spread of the virus within 
these two groups Parameter estimates for these models were to come from a HIV 
survey that was conducted by us at the genito urinary cbmc at St James Hospital 
Dublin We believe that these objectives were realised and the results of this chapter 
are evidence of this
Looking closer at our results, we can see where difficulties were encountered and 
overcome Parameter estimates proved more difficult than we originally thought 
We had hoped to estimate the introduction rates to the IVDU and homosexual 
populations by asking patients the year in which they first used IV drugs or first 
became homosexually active This information could then be combined with esti­
mates of the size of these populations to provide estimates of the numbers entering 
the two groups each year We were unable to do this We found that the majority 
of those surveyed had entered the particular risk group some years previously, none 
had entered in the very recent past We are aware now of one Irish/European study 
that is in progress at the Irish Health Research Board This study will examine the 
incidence of IV drug use and the numbers attending the clinics for the first time 
each year We look forward to the results of this study, when completed it will be 
possible to utilise this data in order to provide a minimum estimate of the numbers 
taking IV drugs for the first time each year. From our own survey, we were able 
to provide a crude estimate of the mean number of people entering the IVDU and 
homosexual populations each year
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We were very fortunate with our survey replies to questions on sexual contacts 
and IV drug use. The number of new partners per unit time is a sensitive and 
difficult question to administer in any survey. We believe that because our survey 
was conducted within a genito-urinary clinic, patient replies were more truthful. 
Staff are well trained and can gain the confidence of the patient. Also, because 
Dublin is a small city medical staff know their patients very well. In estimating the 
param eter on sexual contacts we did not take frequency of sexual contact within 
a partnership into account. This will effect the probability of contacting the virus 
and should be explored further given the availability of suitable data. Replies to 
questions on IV drug use were comprehensive, however little is known about the 
probability of transmission during needle sharing and more research is required into 
this area of the disease.
We chose out of necessity to model the spread of the disease from one drug user 
to another and from one homosexual to another. We have not taken spread from 
the drug user to the ordinary heterosexual or from the homosexual to the bisexual 
into account. Our survey was the first of its kind to be carried out in Ireland, it was 
directed towards the known, primary groups at risk. Now tha t we have seen that we 
can obtain answers to sensitive questions by careful survey design and administration 
by qualified medical personnel we look forward to the extension of this survey work 
to include questions on non IVDU partnerships and bisexual contacts.
Given the models’ limitations we have succeeded in providing preliminary esti­
mates of the level of HIV infection in the IVDU and homosexual populations. We 
know from the National Virus Reference Laboratory that approximately 515 drug 
users and 97 homosexuals tested HIV positive between 1985 and 31st. December 
1989. Our models, given the minimum initial conditions in 1985 predict 647 and 
239 infectious within the drug using and homosexual populations in 1989. If we cal­
culate the size of the IVDU male and female populations in 1980 and introduce one 
infectious male at that time, the model predicts a total of 3,316 infectious drug users 
in 1989. When we estimate from this figure the size of the total number infectious, 
we arrive at an estimate of 5,802 infectious people. We have seen in this chapter 
how this result compares favourably with results from the improved back projection 
method. This encouraged us to look closer at the IVDU model and to give a pre­
liminary assessment of the effects of possible Government intervention policies. In 
Figures 7.10 and 7.11 we saw the results of varying the parameters describing the 
number of new partners per unit time and number of people shared needles with per 
unit time. We saw that the introduction of a needle exchange program, even within 
the course of the epidemic, greatly effects the proportions infectious and with AIDS.
7.9 Conclusions and R ecom m endations.
We started this thesis with a number of quotes which portrayed the myths and uncer­
tainties surrounding the transmission and spread of the HIV virus and AIDS, both 
within Ireland and world-wide. The objective of our work here was to explore these 
unknowns and provide the reader with a more comprehensive picture of HIV and 
AIDS in Ireland. To achieve this, in Chapters 1 and 2 we discussed the background 
to the disease in Ireland and the role of mathematical modelling in describing the 
spread of AIDS. From this we saw where key epidemiological data was lacking. We 
also saw how models to date have concentrated on the spread of the disease within 
the homosexual population. We believe tha t there is an urgent need for more com­
prehensive and detailed data collection on a  national and regional scale. This will
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allow the mathematical modeller to utilise and develop more realistic transmission 
models
In Chapters 3 we estimated the nature and effect of reporting delays on the 
data collection and found them to be minima] in Ireland This is the result of the 
prompt return of information on new HIV positives from the genito urinary clinics 
It is hoped that this will remajn so We also provided estimates of the incidence 
of HIV infection in Ireland given the number of diagnosed AIDS cases We found 
that results relied heavily on both the distribution of the incubation period and the 
nature of the annual growth in AIDS cases Further research is required into both 
these areas of the disease In Chapter 4 we derived a  new and unique solution to the 
integral equation model arising in back projection This allowed us to considerably 
improve upon the estimates of the level of HIV infection derived in Chapter 3 
This new analytical solution can be appked to d a ta  from the U K and The United 
States The extension in the future, of the methods discussed in this chapter, to the 
individual risk groups in Ireland would be desirable, given sufficient data
In Chapter 5 we provided estimates of the minimum number of deaths from 
AIDS This was based on the number of AIDS cases known to the Department of 
Health and the distribution of the length of survival after the onset of AIDS Further 
work on estimates of survival times given the introduction of drugs that prolong the 
bfe of an AIDS patient or the introduction of HIV vaccines are required if estimates 
on the numbers of deaths are to remain accurate
The results of a HIV transmission survey were presented in Chapter 6 This 
provided detailed information on the habits and behaviour of those at risk of HIV 
infection and allowed us to derive in Chapter 7 the first and only estimates of 
transmission model parameters in Ireland The survey results presented in Chapter 
6, particularly those on the habits and frequency of needle sharing and drug use 
have impbcations for the spread of the virus not only in Ireland but world-wide, in 
any country where HIV transmission by IVDU’s is significant For these reasons we 
consider it highly desirable to review the survey questionnaire and to include more 
details on IVDU contacts with heterosexuals The extension of this revised survey 
to other centres would provide invaluable data  and allow the mathematical modeller 
to explore further transmission possibilities
In Chapter 7 we introduced the first deterministic models of the transmission of 
HIV in the Irish IVDU and homosexual populations We provided predictions based 
on these models and the parameters derived from the survey Despite the models’ 
assumptions, we saw that predictions on the numbers HIV positive corresponded 
with results from the improved back projection method It would now be desirable 
to develop these models further in line with the revised survey and to provide a 
more detailed analysis of the models employed
Finally we believe that the work of this thesis is just the first in a series of steps 
that must be taken if the mathematician, and those working with AIDS patients are 
to provide society with the means of understanding and preventing this epidemic
‘There are of course, intellectual and aesthetic satisfactions in under­
standing the mechanisms and processes underlying the natural world, 
but, in the face of misery and suffering on a monumental scale, epidemic 
theory for its own sake is a luxury mankind can ill afford The world 
must not only be interpreted it must be changed ’ Norman T  J  Batley 
1957 [7]
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A p p e n d ix  A
H IV  Transm ission Survey, P ilot 
Survey R eport
A .l  G eneral description o f the survey
P u rp ose o f  th e  survey
The aim of this survey was to investigate the social, sexual and drug habits of those 
at risk from the Human Immunodeficiency Virus (HIV). It was our intention to look 
particularly at the rate of needle use in the drug abusing population and the rate of 
sexual partner change amongst all individuals at risk. In addition to this we aimed 
to estim ate the rate of introduction to each of the at risk populations. This infor­
mation is essential to the construction of any mathematical or statistical models for 
the transmission dynamics of the disease.
M aterial Covered
The participants in the survey were drawn from the Genito Urinary Clinic at St. 
James hospital Dublin. All patients attending the clinic have been tested HIV posi­
tive. There is a total of approximately 300 patients registered at the clinic, although 
not all of these are regular attenders. For the purposes of this pilot survey it was 
agreed with the clinic that twenty patients would be surveyed. It is hoped to survey 
approximately two hundred patients in the final survey. Due to clinic difficulties a 
total of nineteen patients were eventually questioned.
Inform ation  C ollected
The information collected in the pilot survey can be broken down into four cate­
gories. These were,
1. Personal Details.
This section included the patients initials, data  of birth, sex, marital status and 
information on where else the patient was under regular care.
2. History of HIV.
In this section the patient was asked to which risk groups they belonged, whether or 
not they had been tested for the HIV virus and if so when, how frequently and the 
results of these tests. They were also requested to state their CDC classifications 
and if they were classified as stage CDC 4 they were asked to state when they pro­
gressed to  stage 4. In addition to this the patients were asked if they were in receipt 
of any AIDS related drugs and if so when they had first started to receive this drug. 
Within this section patients were asked if they had any sexual contacts other than 
with their regular partner and if so how frequently. They were then asked questions 
similar to  earlier questions on the HIV status of their regular partner.
3. Risk Activity.
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Within this section patients were asked to list their sexual orientations and the age 
at which they became heterosexuaHy active They were then asked a series of ques­
tions relating to the rates of partner change and use of contraceptives Within this 
section patients were asked if they had ever abused intravenous drugs If so they 
were then requested to give estimates on the extent of their drug use, needle sharing 
and the lifetime of their needles Patients were also asked at what age they first 
abused intravenous drugs Female patients in this section were asked if they had 
given birth since becoming HIV positive and if so they were then asked to provide 
details on the HIV status of their children 
4 Homosexual Activity
This section requested those who engaged in homosexual activity to answer ques­
tions on their sexual activity similar to those asked of heterosexuals Finally patients 
were asked to list any other relevant information 
M e th o d  o f d a ta  co llec tio n
The data described above was collected by the medical staff at the chiuc This 
included the consultant, the senior registrar and a research nurse The survey was 
administered by the staff while patients were attending the dime for reasons asso­
ciated with their HIV status 
Sam pling  M eth o d
The nineteen patients involved in the pilot survey were questioned on a first come
first served basis
A ssessm en t
The primary ajm of this pilot survey was to assess its feasibihty, to access accuracy 
of replies and time involved in administering the survey We found that it took 
approximately one month to survey nineteen patients We also found that some of 
the survey questions were misunderstood This was apparent from certain incon­
sistencies in patient replies We shall examine this aspect in more detail in later 
sections Finally we feel that the pilot was very successful as it brought to bght 
patients’ misunderstandings and willingness to answer sensitive questions
A .2 Statistical A nalysis
In tro d u c tio n
Within this section we propose to give a brief description of the steps followed 
to ensure accuracy, the equipment utibsed in the statistical analysis and finally a 
discussion of the results of the pilot survey 
A ccu racy  an d  E q u ip m en t
All questionnaires were read and checked prior to data entry Each questionnaire was 
then assigned a case number for ease of reference Data was entered onto the VAX 
via kermit and the word processing package Wordstar D ata was entered in fixed 
format with each variable being assigned a short variable name and fixed position 
Hardcopy records of the variable names and positions were kept Approximately 
one hundred variables were identified SPSSX the statistical package for the social 
sciences was used to analyse the d a ta  In order to shorten subsequent command files 
all data definitions and derived variables were stored in system files These could 
then be readily accessed The statistical analysis of the pilot survey was broken 
down into several sections which followed along the bnes of the sections within the 
survey itself 
P e rso n a l D etails
The initials and date of birth  of each patient were crossed checked From this we
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saw that no patient was interviewed more than once The distribution of the sex of 
the patients was examined and can be seen in Table A 1 below While the ratio of 
males to females is almost one to one in the pilot we believe that this will not be the 
case in the final survey as there approximately 76 female HIV positives attending 
the gem to-urinary clinic at St James and there are over 200 male HIV positives in 
attendance
Table A 1 
PATIENTS SEX
FREQUENCY %
MALE 10 52 6
FEMALE 9 47 4
TOTAL 19 100 0
The majority of the patients m the pilot survey were single We beheve that in the 
final survey we shall not require such detailed information on the marital status of 
the patients Our primary interest is in knowing whether or not the patient is in 
a stable relationship This question has been adjusted accordingly A table of the 
marital status of the patients surveyed is provided below
Table A 2 
PATIENTS MARITAL STATUS
FREQUENCY %
SINGLE 12 63 2
COHABITING WITH A MALE 2 10 5
MARRIED 3 15 8
DIVORCED SEPARATED 1 5 3
TOTAL 18 100 0
The age of the patients was derived from their dates of birth The mean age of those 
questioned was 27 years and ages ranged from 18 years to 38 years The distribution 
of the patients ages is given below m Table A 3




22 2 10 5
23 1 53
24 1 5 3
25 1 53
26 1 53
27 2 10 5
28 1 53
29 2 10 5
30 2 10 5





TOTAL 19 100 0
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Cross tabulations of age with risk group were produced in order to examine the age 
distributions within each of the risk groups We found that the drug abusing group 
was the youngest while the homosexual group tended to be older Some patients 
were classified under more than one risk group A summary of the information in 
these cross tabulations are provided in Table A 4
Table A 4 
AGE WITHIN RISK GROUP
Risk Group Mean Age Range No of patients
Drug Abuser 25 18 to 34 7
Reformed drug abuser 27 22 to 33 9
Homosexual 33 29 to 38 2
Bisexual 26 none 1
Partner of HIV positive 30 26 to 33 3
Other risk 30 none 1
H IV  S tatus
All patients questioned had been tested for the HIV virus All patients were HIV 
positive Many patients had been tested more than once When questioned on the 
dates of these tests and their results many patients could not remember All patients 
remembered when they first tested positive with the exception of three patients 
who tested positive some time in 1985 As the patients experienced difficulty in 
remembering all dates this question has been modified for the final survey We shall 
now question patients on the date of their last negative test (if applicable) and the 
date of their first positive test The distribution of the number of tests per patient 
are given in Table A 5 below We found that the mean number of tests per patient 
was two, with the number of tests ranging from one to seven
Table A 5 
NUMBER OF TIMES TESTED
TIMES TESTED FREQUENCY %
1 12 63 2
2 3 15 8
4 1 53
7 2 10 5
MISSING 1 53
TOTAL 18 100 0
How long patients have been positive for was derived from the date of the survey 
(July 1989) and the dates the patients tested positive This of course will not provide 
a  completely accurate picture of the duration of the patients incubation periods due 
to  the fact that patients may have been HIV positive long before they were tested 
for the virus For these reasons we feel that the question on the date of the patients 
last negative result (if patients can recall this) is of the utmost importance The 
length of time the patients have been positive was computed in months We found 
that this time ranged from as little as one month to as long as fifty nine months with 
the mean length positive at twenty nine months The distributions of the durations 
positive are provided in Table A 6 below
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Table A 6
DISTRIBUTIONS OF DURATIONS POSITIVE (In months)
MONTHS FREQUENCY %
1 1 5 3
2 1 53
5 1 5 3
6 1 5 3
8 10 5
18 1 5 3
20 1 5 3
25 1 5 3
30 1 5 3
38 1 5 3
42 1 5 3
44 1 5 3
46 1 5 3
49 15 8
56 1 5 3
59 1 5 3
TOTAL 19 100 0
The mean duration HIV positive was seen to be 29 21 months and the standard 
deviation was 20 15 months
Patients were next asked to state their CDC classification When the pilot survey 
was designed we were unaware that a patient could be classified under more than one 
stage The main survey has been modified accordingly If patients were classified as 
CDC stage 4 they were then asked to state when they had progressed to this stage 
We also asked in the pilot if patients were in receipt of any AIDS related drugs and 
if so what drug and when did they first start to receive this drug We have found 
in the pilot that all patients who progress to stage 4 receive Retrovere immediately, 
this question has therefore been modified accordingly It is also interesting to note 
that those patients who are in the AIDS classes (CDC4C1, CDC4C2, CDC4D and 
CDC4E) have been HIV positive for longer than those who are not classified as 
having AIDS, see Table A 7
Table A 7
MEAN LEHGTH POSITIVE WITHIN CDC CLASSIFICATION
CDC Stage Length Pos Range No in Class
CDC1 0
CDC2 14 8 1 to 42 6
CDC3 30 7 5 to 49 6
CDC4C1 33 7 5 to 59 6
CDC4C2 33 5 18 to 49 2
CDC4D 0
CDC4E 46 1
Partners H IV  Status
Patient replies to the questions on sexual contacts with regular and alternative part­
ners proved to be very inconsistent This may have been due to the sensitive nature 
of the questions and/or the design of these questions Also patients could not state
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with any certainty if their regular partner had been tested for the HIV virus and 
if so the results of the test Only 11 of the 19 patients say tha t their partner has 
been tested yet 12 patients gave the results of their partners test For these reasons 
part of this section in the final survey has been om itted and questions have been 
rewritten in a less sensitive way 
H e te ro sex u a l R isk  A c tiv ity
Within this section we first asked patients to state their sexual preference We then 
questioned on the nature and extent of their sexual contacts In addition we also 
questioned patients on their use of contraceptives Of the 19 patients surveyed 15 
were heterosexual, 2 homosexual and 2 were bisexual Looking first at the replies 
relating to heterosexual activity we found that 6 patients missed the question on age 
at first heterosexual contact and 2 patients said tha t it was non applicable As this 
is one of the central questions to the survey (as the data  is needed to estimate the 
introduction rates to the sexually active populations) we have moved it to a more 
prominent position in the final survey The mean age of first heterosexual contact of 
the eleven rephes to this question was 16 64 years with a standard deviation of 2 46 
years and a range of 13 to 22 years The mode was also 16 years Sexual permissive­
ness was not evident from the replies Twelve of seventeen patients are reported as 
having a single sexual partner m the past year The number of partners in the past 
five years per patient ranged from none to fifty Eleven of the seventeen patients said 
that they had no partners within the previous month As our sample size was very 
small and the questions very sensitive the mam survey was considerably modified 
Patients will not now be asked directly to quantify their number of partners When 
asked about contraception 9 of the 17 heterosexually active (15 heterosexuals and 2 
bisexuals) patients said that they never used any form of contraceptive 5 patients 
said that they sometimes did and only 2 patients said tha t they always used some 
form of contraception Of the 7 patients who used contraceptives 6 said that they 
used condoms Homosexual activity was analysed separately 
H om osexual R isk  A c tiv ity
Of the 19 patients who answered the pilot survey 2 males said that they were homo­
sexual and one male said that he was bisexual Because of such a small sample size 
replies to the questions on homosexual practices shall be summarised briefly The 
average age at first homosexual activity was seen to be 15 3 years with a range of 
12 to 21 years When questioned on the number of homosexual partners in the last 
5 years replies ranged from none to 365 2 patients said tha t they had no partners 
in the last year while one patient said he had one None of the patients had had 
any partners within the previous month Patients engaged in a range of homosexual 
activity but when questioned on the use of condoms 2 patients said tha t they never 
used them It is difficult to deduce any relevant information from this sample due 
to its size and the range of replies given by the three patients 
I  V  D rug U se
Sixteen of the nineteen patients said that they do or did use needles Each of the 16 
said that they also shared needles Fourteen of these said that they had not shared 
within the last week The range of injections per person per day was between 1 and 
10 with the range per week of 3 to 42 Tables of these frequency distributions are 
given below
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Table A  8
NUMBER FREQUENCY %
1 2 10 5
3 6 31 6
4 3 15 8
5 2 10 5
6 2 10 5
10 1 5 3
MISSING 3 15 8
TOTAL 19 100 0
The mean number of IV injections per day was 4 and the standard deviation was 
2 16 The mean number per week was just under 26 and the standard deviation was 
11 32 The age of first needle use varied from 13 to 26 years with the mode at 15 
years and the mean age at 17 1 yeaxs This distribution is given in Table A 9
Table A 9
AGE FREQUENCY %
13 1 5 3
14 1 5 3
15 5 26 3
16 1 5 3
17 3 15 8
18 2 10 5
20 1 5 3
23 1 5 3
26 1 5 3
MISSING 3 15 8
TOTAL 16 100 0
The mean age of first IV drug use was 17 13 years and the standard deviation was 
3 40 years We saw from the survey th a t all of the heterosexuals and bisexuals with 
the exception of one patient used needles This one heterosexual patient contracted 
the virus in an African country Neither of the two homosexuals used needles We 
also found that of the 16 patients using needles 8 were male and 8 female This is 
maybe due to the fact that we had 9 females and 10 males participating in the pilot 
We do not expect to get even numbers of males and females in the final survey due 
to  the fact that there are more HIV positive drug using males than females
A .3 C onclusion
The primary aim of this pilot survey was to test the feasibility of a major survey 
with sensitive questions on the sexual habits and drug use of HIV positive patients 
Questions in the survey were designed to give us the necessary information on essen­
tial mathematical model parameters This information is needed in order to provide 
long term estimates of the prevalence of the HIV virus and eventual AIDS cases m 
Ireland
The pilot was very successful as it highbghted patients’ misunderstandings about 
certain questions It also demonstrated to us that we could not expect to get accurate
A7
quantitive details in certain questions In addition to this we found that one of the 
central questions that of the age of first heterosexual contact was missed by the 
interviewers This question has now been moved to a more prominent position 
Data from the repbes was sketchy due to the small sample sizes, particularly m the 
homosexual group For this reason preliminary estimates of the model parameters 
are unlikely to reflect the true situation
Finally one must stress to other researchers the importance of a preliminary pilot 
survey this we feel is reflected in our results
A8
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H IV  Transm ission Survey  
Q uestionnaire
B1
HIV TRANSMISSION MODEL SURVEY
Prof A D Wood, Ms H Ruskin, Ms C Comiskey, Dublin City University, Dubbn 
Interview Details
Hospital/Clinic name






Dubita 9 Telephone 




SECTION 1 PERSONAL DETAILS
1 lnitals of the patient
2 Patients date of birth
3 Patients sex 1 ) Male 2) Female
4 Please bst the patients risk category
1 ) Male I V D U only
2) Female I V D U
3) Male homosexual only
4) Male bisexual
5) Male homosexual or bisexual and I V D U
6) Other, please specify
5 Is the patient
1 ) Cohabitating with a male
2) Cohabitating with a female
3) Living single













6) Not under regular care elsewhere ¡4
7) Others, please specify S’
7
B2
SECTION 2 HIV DETAILS
1 How many times has the patient benn tested for HIV7
2 Please give the approximate dates of the patients
a) first positive test, (state month and year)
b) last negative test, (state month and year)
3 If you have a regular partner are they HIV positive
1 No
2 Yes
3 Do not know
4 No regular partner
If yes when did they test positive, state month and year










10 Patient not classified
5 If CDC 4, please give the date when the patient progressed to stage 4 
(state month and year)
SECTIQN-3a HETEROSEXUAL PARTNER DETAILS
1 Would you describe your sexual activity pattern as
1 Non-existent
2 Seldom or occassional - at least once a month
3 Frequent - at least once a week
4 Very frequent - at least once a day









3 At present would you say that your average number of partners per month was
1 No partners
2 One partner
3 Two to five partners
4 Six to ten partners
5 More than ten partners
4 At present what is your average number of partners per year7
5 At what age did you become hetrosexuaUy active7




7 What sort of contraceptive do you or your partner use7
1 Condoms
2 Oral contraceptives
3 Condom plus another form of contraceptive
4 Coil
5 Sterilization
6 Other, please specify
7 None
SECTION 3b HOMOSEXUAL PARTNER DETAILS
1 Would you describe your sexual pattern as
1 Non-existent
2 Seldom or occasional - at least once a month
3 Frequent - at least once a week
4 Very frequent - at least once a day










3 At present would you say that your average number of partners per month was
1 No partners i □
2 One partner
3 Two to five partners
4 Six to ten partners
5 More than ten partners
4 At present what is your average number of partners per year7









7 At what age did you become homosexually active7 
SECTION 4 DRUG USE DETAILS
1 Have you used intravenous drugs in the past7 
1 ) No 2) Yes
2 Are you using intravenous drugs at present7
1 No, stopped when became HIV positive
2 No, stopped when became pregnant
3 No, stopped for other reasons, please state
4 Yes, am using IV drugs at present
If no, please state month and year when stopped
3 Please answer the following
1 Age of first needle use
2 How often would you inject each week7
3 How often would you inject each day7
4 How many people would you share a needle with in one week7
5 How long would a needle last7
(a) Less than one week
(b) One to two weeks
(c) Two to four weeks






Has this pattern changed since you became HIV positive7
1 Less frequent use
2 No change
3 More frequent use
If you are female and HIV positive
Have you given birth since becoming HIV positive7
1) No 2) Yes
If yes,
(a) How many bve deliveries have you had7 
1) 1 2) 2 3) 3
4) More than 3, please specify number
(b) Were any of these twins7
1) No 2) Yes
If yes, please give number of set of twins







Any positive results 1) No 2) Yes 
Date of positive result 
Result of last test 1) Neg 2) Pos 
Date of last test
1st Child 2nd Child 3rd Child
Any other relevant information
B6
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A ppendix C
N um erical A nalysis
C .l Introduction
The transmission of HIV infection within the Irish IVDU and homosexual popula­
tions was described in Chapter 7 The NAG library routine D02EBF [38] was used 
to solve these systems of non bnear differential equations The reader is provided 
below with a simple driver program, in double precision, for use with this routine 
We show here the program for the IVDU model, given certain known mital condi­
tions This program can easily be modified for use with the system of equations 
describing the homosexual model
C.2 Program  Listing
C HIV TRANSMISSION MODEL SOLVER D02EBF
C MINIMUM ESTIMATES, IVDU POPULATION MODEL
C
IMPLICIT NONE 
C SCALARS IN COMMON













EXTERNAL FCN, OUT, PEDERV 


























CALL D02EBF(X, XEND, N, Y, TOL, IR, FCM, MPED, PEDERV,
+ OUT, W, IV, IFAIL)
WRITE (NOUT,99997) IFAIL




99999 FORMAT (IX,’CALCULATION WITH TOL=\ 1PD11 4)
99998 FORMAT (1X,’X AND SOLUTION AT EQUALLY SPACED POINTS')
99997 FORMAT (1X,’IFAIL=\ 12)
99996 FORMAT (4(IX/),IX,’D02EBF HIVSYS2 PROGRAM RESULTS»,/)
99995 FORMAT (IX,7RANGE TOO SHORT FOR TOL’)













































SUBROUTINE PEDERV(X, Y, P¥)










C SCALARS IN COMMON
REAL*8 H, XEND 
INTEGER I 
C LOCAL SCALARS
INTEGER J, NOUT 
COMMON XEND, H, I 
DATA NOUT /2/
WRITE (NOUT,99999) X, (Y(J), J=l,8)
X=XEND - FLOAT(I)*H 
1=1-1 
RETURN
99999 FORMAT (1X,1PD11 4,8(2X,1PE12 5))
END
C3
A ppendix D ,














SPSSX command file showing all data 
definitions, records, variable names and 
labels used in the analysis of HIV Survey
Analysis of Section 1 personal details, 
of HIV Survey, includes information 
for all risk groups
Analysis of Section 2, HIV incubation 
details, for risk group 1 (male IVDU)
As above, but for risk group 2, (female 
IVDU)
As above, for risk group 3, (male homo­
sexual)
As above, for risk group 4, (male 
bisexual)
As above, for risk group 5, (male homo­
sexual/bisexual and IVDU)
As above, for risk group 6, (male and 
females with other risks)
Analysis of Section 3A of HIV Survey, 
heterosexual partner deatails, for 
risk group 1
As above, for risk group 2 





As above, for risk group 5
As above, for risk group 6
As above, for risk group
only




[1] Anderson, R M (1989) Mathematical and Statistical Studies of HIV A ID S , 
Vol 3, No 6, 333-346
[2] Anderson, R M (1988) The Epidemiology of HIV Infection, Variable Incuba­
tion plus Infectious Periods and Heterogeneity in Sexual Activity Journal o f  
The Royal Statistical Society A , 151, 66-93
[3] Anderson, R M  and May R M  (1988) Epidemiological Parameters of HIV 
Transmission Nature , Vol 331, 514-519
[4] Anderson, R M and Medley, G F (1988) Epidemiology, HIV infection and 
AIDS the incubation and infectious periods, survival and vertical transmission 
A ID S , Vol 2,(suppl 1)
[5] Anderson, R M , Medley, G F , May, R M and Johnson, A M (1986) A pre- 
bminary study of the transmission dynamics of the human immunodeficiency 
virus (HIV), the causative agent of AIDS IMA Journal o f Mathematics A p ­
plied m Medicine and Biology, 3, 229-263
[6] Bailey, N T J (1988) Simplified Modelling of the Population Dynamics of 
HIV/AIDS Journal o f The Royal Statistical Society A , 151, 31-43
[7] Bailey, N T J (1975) The Mathematical Theory o f  Infectious Diseases and its 
Applications, 207-219 Griffin and Co Limited Second Edition (First Edition 
1957 )
[8] Birch, M W (1963) Maximum likelihood m three way contingency tables 
Journal o f The Royal Statistical Society B  25, 220-233
[9] Blythe, S P and Anderson, R M (1988) Distributed incubation and infec­
tious periods in models of the transmission dynamics of the human immunod­
eficiency virus (HIV) IMA Journal o f Mathematics Applied in Medicine and  
Biology Vol 5 1-19
[10] Brookmeyer, R and Damiano, A (1989) Statistical methods for short-term 
projections of AIDS incidence Statistics m  Medicine, Vol 8, No 1, 23-34
[11] Brookmeyer, R and Gail, M (1988) A method for obtaining short term pro­
jections and lower bounds on the size of the AIDS epidemic Journal o f the 
American Statistical Association, 83, 301-308
[12] Brookmeyer, R and Gail, M (1987) Methods for predicting the AIDS epi­
demic Lancet, 2, 11
[13] Brookmeyer, R and Gail, M (1986) Minimum size of the acquired immunode­
ficiency syndrome (AIDS) epidemic in the United States Lancet, 2, 1320-1322
[14] Burden, R L and Faires, J D (1985) Numerical Analysts, 136-141 3rd Edi­
tion Pnndle, Weber and Schmidt, Boston
[15] Comiskey, C M , Ruskin, H and Wood, A D (1990) The estimation of the 
incidence of HIV infection in Ireland using the back- projection method Sub­
mitted for pubbcation
[16] Cox, Sir D (1988) Short-term prediction o f  H IV  infection and A ID S  in Eng­
land and Wales Her Majestys Stationary Office
[17] Curran, J W , Morgan, W M , Hardy, A M , Jaffa, H W , Darrow, W W and 
Dowdle, W R (1985) The Epidemiology of AIDS Current Status and Future 
Prospects Science 229, 1352-1357
[18] Dietz, K (1988) The dynamics of spread of HIV infection in the heterosexual 
population Statistical Analysis and Mathematical Modelling of AIDS,  77-105
[19] Dobson, A J (1983) A n introduction to statistical modelling Chapman and 
Hall Ltd
[20] Downs, A M , Ancelle, R A , Jager, H J C and Brunet, J B (1987) AIDS in 
Europe Current Trends and Short-Term Predictions Estimated from Surveil­
lance Data, January 1981 - June 1986 AID S,  Vol 1, No 1
[21] El-gendi, S E (1969) Chebyshev solution of differential, integral and mtegro- 
differential equations Computer Journal , 12, 282-287
[22] Gill, P E  and Miller, G F  (1972) An algorithm for the integration of un­
equally spaced data  Computer Journal  15, 80-83
[23] Gradsheteyn, IS  and Ryzhik, IM  (1980) Tables o f Integrals, Series and  
Products, 933-940 Corrected and enlarged edition Academic Press Inc
[24] Hethcote, H W and Yorke, J A (1985) Gonorrhea Transmission Dynamics 
and Control Lecture Notes in Biomathematics , 56 Springer
[25] Isham, V (1988) Estimation of the incidence of HIV infection - the back 
projection method Department of Health Report o f a working group on short 
term prediction o f  H IV  infection and A ID S  in England and Wales 53-55
[26] Isham, V (1988a) Mathematical Modelling of the Transmission Dynamics of 
HIV infection and AIDS a review Journal o f  the Royal Statistical Society A , 
151, 5-30
[27] Jerri, A J (1985) Introduction to Integral Equations with Applications, 82-87 
Dekker, New York
[28] Kermack, W 0  and McKendrick, A G (1927) Contributions to the m athe­
matical theory of epidemics Proceedings o f  the Royal Society >1,115, 700-721
[29] Johnson, A M , Wadsworth, J , E lbott, P , Prior, L , Wallace, P , Blower, S , 
Webb, N L , Heald, G I , Miller, D.L , Adler, M W., Anderson, R M. (1989). 
A pilot study of the sexual lifestyle in a  random sample of the population of 
Great Britain A ID S , 3 135-141
[30] Linz, P (1985) Analytical and Numerical Methods fo r  Volterra Equations 
SIAM Philadelphia
[31] Marasca, G , McEvoy, M (1987) Length of survival of patients with acquired 
immune deficiency syndrome m the United Kingdom British Medical Journal, 
229, 1727-1729
[32] May, R M (1988) HIV infection in Heterosexuals Nature, Vol 331, 655-656
[33] May, R M and Anderson, R M (1987) Transmission Dynamics of HIV Infec­
tion Nature, Vol 326, 137-142
[34] McCullagh, P and Nelder, J A (1983) Generalized Linear Models Chapman 
and Hall, London
[35] Medley, G F , Anderson, R M , Cox, D R and Billard, L (1987) Incubation 
period of AIDS m patients infected via blood transfusion Nature , 328, 718-721
[36] Moser, C A (1957) Survey Methods in Social Investigation Wilham Heine- 
mann Ltd
[37] Murray, J D (1989) Mathematical Biology Biomathematics, Vol 19,610-624 
Springer Verlag
[38] N A G  Fortran Library Manual (1984) Mark 11, Vol 2 Numerical Algorithms 
Group, Oxford
[39] Nelder, J A and Wedderburn, W M (1972) Generalized Linear Models Jour­
nal o f The Royal Statistical Society A  135, part 3, 370-384
[40] Olver, F W J (1974) Asymptotics and Special Functions, 66-67 Computer 
Science and Applied Mathematics Series Academic Press Inc
[41] Payne, C D (1985) The generalised linear interactive modelling system, 
(GLIM)  Release 3 77 Manual, Numerical Algorithms Group, Oxford
[42] Reeves, G K (1988) The Overall Distribution of Survival Time for U K AIDS 
patients Report o f  a working group on short-term prediction o f  H IV  infection 
and A ID S  in England and Wales, 80-81 Her Majestys Stationary Office
[43] Reeves, G K and Overton, S E (1988) Prebminary Survival Analysis of U K 
AIDS data Lancet, 1,880
[44] Ross, R (1911) The Prevention o f  Malaria 2nd Ed Murray, London
[45] Sanchez, D A (1968) Ordinary Differential Equations and Stability Theory 
A n Introduction  Dover Publications Inc
[46] Sato, P A , Chm, J and Mann, J (1989) Review of AIDS and HIV infection 
global epidemiology and statistics A ID S  3, (supp 1) s301-s307)
[47] W H O  (1989) AIDS Surveillance in Europe, Quarterly Report No 24 WHO 
Collaborating Centre on A ID S
[48] Wyhe, C R and Barret, L C (1985) Advanced Engineering Mathematics 
McGraw-Hill Book Company
